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Protein pharmaceuticals, like monoclonal antibodies (mAbs), are sensitive to many 
degradation pathways, such as oxidation and photodegradation. Photostability testing provides 
essential information to characterize protein stability because mAbs are exposed to light during 
the production and storage process, which could lead to instability problems. Photostability 
testing has also become increasingly important to demonstrate likeness between biosimilars and 
original protein therapeutics. All amino acids are sensitive to oxidation, but only the aromatic 
amino acids and the disulfide bond are directly sensitive to light. The Trp residue is the most 
sensitive to light, and its photochemistry has been studied extensively, but the photochemistry 
involving both Trp and the disulfide bond in peptides and proteins has not been fully 
characterized, although the Trp residue is frequently located near disulfide bonds. To improve 
our understanding of the mechanisms of degradation and stability of protein pharmaceuticals, we 
have exposed disulfide-containing, Trp-containing, and disulfide and Trp-containing peptides, 
and an IgG1 molecule to light at λ = 254 nm and/or λmax = 305 nm. By mass spectrometry, 
chemical derivation, and NMR analysis, we observed a novel Cys crosslinked product after 
photoirradiation, tentatively identified as isothiazole-3(2H)-one. By mass spectrometry, we 
observed cleavage of the Trp side chain to Gly and/or Gly hydroperoxide in IgG1 at three 
separate Trp residues located in both the heavy and light chains, all of which were within close 
proximity to a disulfide bond. We also detected the cleavage of the Trp side chain to Gly and/or 
Gly hydroperoxide in two model peptides. In a third model peptide, we observed the cleavage 
and trapping of the Trp side chain by nearby Lys and Tyr residues. The Cys crosslink and Trp 
cleavage products highlight the damage light exposure can have by not only inducing a 
significant amino acid modification, but also leading to protein aggregation or amino acid 
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1.1 The emergence of antibodies in the biotechnology industry 
The biotechnology industry is becoming increasingly interested in developing protein 
pharmaceuticals as therapeutic agents on a large scale, evidenced by the 47 approved antibodies 
in the US or Europe and over 300 molecules currently in development since the first protein 
therapeutic, human insulin, was approved by the Food and Drug Administration (FDA) in 
1982.1,2,3,4,5 These protein pharmaceuticals are effective against a variety of cancers,6 
autoimmune disorders,7 and inflammatory diseases.8  Novel antibody therapeutics and related 
products have emerged in recent years such as antibody-drug conjugates (ADCs), bispecific 
antibodies, Fc-fusion proteins, and biosimilars.5 The advantage of using protein pharmaceuticals 
over small molecule drugs stems from their effectiveness at lower concentrations, reduced side 
effects, their affinity to bind target molecules, and their utility in combination with other 
therapies and radioisotopes.9 Antibodies also show increased stability over other protein 
pharmaceuticals because of their disulfide-rich nature, but they are still sensitive to a number of 
chemical and physical instabilities: oxidation, photochemical degradation, denaturation, 
aggregation, etc.9,10,11,12,13 Oxidative and photochemical damage, collectively photo-oxidation, 
could occur after antibodies are exposed to light during formulation or storage, and this damage 
could enhance immunogenicity or cause inactivation.10,14,15,16 To increase the stability of these 
antibodies, an understanding of their mechanisms of degradation is necessary.  
1.2 Light exposure in the biotechnology industry 
In the biotechnology industry, proteins are often exposed to light during the 
manufacturing, purification, storage, and administration processes.12 Small-scale (2L) culture 
processing is often done in glass bioreactors, where the protein is exposed to various levels of 
ambient light, which has been documented to cause an unwanted increase in acidic variants.17 
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UV detection at 280 and 300 nm is frequently used to monitor and subsequently separate and 
purify proteins, which could induce protein degradation.18 While most protein therapeutics are 
now stored properly without possibility of light exposure, during administration through 
intravenous injection, they could be exposed to light in clear IV bags. To ensure that light 
exposure does not degrade protein therapeutics (or small molecule drugs) to an unacceptable 
level and affect safety, a set of photostability testing guidelines was reached by the International 
Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals 
for Human Use (ICH).19  Under this regulation, Q1B, photostability testing must be carried out 
on the drug substance (containing only the active pharmaceutical ingredient (API) exerting 
pharmacological action in the buffer or vehicle it will be delivered, e.g. the protein) and on the 
drug product (containing the API and other non-active ingredients (such as excipients, e.g. 
sugars, surfactants) that will be sold commercially). To comply with the Q1B, the samples must 
be exposed to at least 1.2 million lux hours of visible light and 200 watt hours/m2 of UV light 
using approved light sources, although revisions to this guideline have been recommended.20,21  
1.3 Protein photo-oxidation  
Photo-oxidation may lead to a change in the overall protein structure (e.g. aggregation or 
fragmentation)22, however, these reactions are only targeted to a select group of amino acids. 
Disulfides and the aromatic amino acids tryptophan (Trp), phenylalanine (Phe), and tyrosine 
(Tyr), are most susceptible to UV irradiation between 250-320 nm.23,24,25,26 Oxidation reactions 
mainly occur with the aforementioned amino acids, as well as histidine and methionine.12,22 
Figure 1.1 shows the absorbance spectra of the disulfide bond and the aromatic amino acids.27 
Trp has the highest extinction coefficient in the near-UV region compared to the other residues, 
with its absorption maxima at 280 nm, and absorbing light over 300 nm. Above ca. 290 nm is the 
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cutoff for Pyrex glass, allowing Trp to absorb 
light during conditions when a protein is stored 
in glass. The disulfide bond, although of much 
lower intensity, also absorbs light past 300 nm, 
with its absorption maxima at 254 nm. Tyr 
absorbs light at a higher intensity than the 
disulfide bond, with its absorption maxima at 
275 nm, but not absorbing light past 290 nm. 
Phe, however, absorbs light with similar 
efficiency as the disulfide bond.  
After exposure to light, photooxidation 
of proteins occurs by either a direct (type I) or indirect (type II) process.28 In the type I process, 
UV light is directly absorbed by a protein chromophore (e.g. Trp), creating an excited state or 
radical species. In the type II process, an excited chromophore transfers its energy to ground 
state triplet oxygen (3O2), forming singlet oxygen (
1O2), superoxide (O2·
-), peroxy radicals 
(ROO·) or hydroxyl radicals (HO·) which react with other residues in the protein. In the 
following sections, we will primarily focus on disulfide and Trp photochemistry, and on the 
interaction between the two moieties.  
1.4 Disulfide photochemistry 
Cys disulfides often play a role in the three-dimensional structure of proteins; for 
instance, Y-shaped antibodies usually contain at least four interchain disulfides linking the two 
heavy chains and the heavy and light chains, along with more intrachain disulfides.9 Although 
disulfides can stabilize proteins, they are sensitive to light, heat, and high pH, and will undergo 
Figure 1.1. Absorbance spectra of the disulfide bond 
(CysSSCys), Trp, Tyr, and Phe.27  
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heterolytic cleavage to yield a thiolate (RS-)29, or homolytic cleavage to yield a thiyl radical pair 
(RS·).30 For example, at high pH, cleavage of the disulfide through β-elimination results in the 
formation of persulfide (RS-S-) and dehydroalanine, an unstable molecule that can form 
unnatural cross-links with nucleophilic amino acids such as lysine.31 The persulfide can lose one 
sulfur to form the thiol product (RSH), which can undergo two-electron oxidation to form the 
disulfide again, or form sulfenic acid (RSOH), sulfinic acid (RSOOH), or sulfonic acid 
(RSO3H).32  
The less studied one-electron oxidation of Cys produces thiyl radicals (CysS·), and the 
one-electron reduction of a disulfide produces disulfide radical anions (RS-SR·-), which may 
undergo disproportionation to yield a thiol (RSH) and thioaldehyde (R=S) (Figure 1.2).30  Based 
on theoretical calculations of a relaxed model peptide, the S-H bond has higher bond dissociation 
energy (BDE) than the αC-H bond of other amino acids, indicating a thermodynamic preference 
for hydrogen-atom (H-atom) abstraction by thiyl radicals.33 To probe H-atom abstraction 
reactions with thiyl radicals, Mozziconacci et al. used model peptides containing disulfides with 




flanking alanine residues. 
To study the H-atom 
abstraction between the S· 
and C-H bonds, the model 
peptide was irradiated in 
both water (H2O) and 
deuterium oxide (D2O), 
and the resultant deuterium 
incorporation after 
irradiation on C-D bonds 
confirmed H-atom transfer reactions (more details to follow in Chapter 2).34 These experiments 
showed not only αC-H abstraction by the thiyl radicals, but βC-H abstraction as well, which 
should have been less favorable than the αC-H abstraction since radicals are less stable on 
secondary carbons than on tertiary carbons. Consequently, these H-atom transfer reactions led to 
the transformation of Cys into Ala and dehydroalanine, and Ala into dehydroalanine.  
1.5 Tryptophan photochemistry 
Trp is a unique amino acid, often used as an intrinsic probe to detect conformational 
shifts due to environmental changes in pH, temperature, solvent, or protein interactions. Trp is 
useful to see such conformational changes because of its strong absorbance at 280 nm and 
fluorescence emission at 348 nm. However, the indole structure making Trp so useful for 
probing protein dynamics also makes Trp susceptible to light-induced damage; Trp residues play 
a major role in the activation of protein photodegradation, and their photoinduced processes are 
numerous (See Figure 1.3).23,35 After photochemical excitation, Trp is excited to its singlet state 
Figure 1.3. Light-induced degradation of Trp, and its reaction with disulfides, 




(1Trp) where it can fluoresce, intersystem cross to its triplet state (3Trp), or undergo 
photoionization to a Trp radical cation (Trp·+), while ejecting an electron (e-aq). The 
1Trp can 
reduce the nearby peptide backbone, and either the 1Trp or e-aq can reduce a disulfide through a 
one-electron transfer. If there is a proton in the solution, the newly reduced RSSR·- will react 
with it to form a thiyl radical, leading to the cascade of other photochemical reactions discussed 
in the previous disulfide photochemistry section. The 3Trp will either phosphoresce back to the 
ground state Trp or react with 3O2 to form N-formylkynurenine (NFK), 
1O2, or O2·
-.  
Many studies have been aimed to identify Trp photoproducts and reaction mechanisms. 
23,36,37,35,38 Some products identified after irradiation of the amino acid form of Trp at λ = 254 nm 
under slightly acidic, anaerobic conditions include: alanine (Ala), serine (Ser), aspartic acid 
(Asp), tryptamine, kynurenine (Ky), and N-formylkynurenine (NFK).23 Under aerobic conditions 
at λ = 254 nm, the main Trp photoproduct was NFK, which underwent secondary photolysis to 
Asp, Ser, Ala, Ky, and ammonia.23 Ky and NFK are important photoproducts because they are 
endogenous photosensitizers, absorbing light at 365 and 325 nm, respectively, above the cutoff 
for transmission through glass at ca. 290 nm.39,40 Ky is also a well-studied degradation product, 
having been linked to neurodegenerative disorders like Alzheimer’s and Huntington’s disease.41 
1.6 Tryptophan and disulfide interactions 
In proteins, Trp is a common neighbor of disulfides, and, as seen in Figure 1.3, disulfides 
are common quenchers of the excited Trp residue.42 Although much has been studied about the 
photochemistry of disulfides and Trp separately, our understanding of the photochemistry of 
their interaction is limited. The first Trp-mediated photolysis of disulfides within a protein was 
seen in F. solani pisi cutinase, and since then, other proteins, such as goat α-lactalbumin and 
bovine somatotropin, have shown similar results.43,44,45 In goat α-lactalbumin, there has also been 
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evidence of a Trp-Cys crosslink after photolysis.46 The photochemistry of disulfides and Trp 
separately is complex, so the photochemistry involving both residues will be much more 
complex, and this leaves much to be studied in this area. 
1.7 Aim and outline of this dissertation 
 As outlined in this introduction, protein stability, and specifically photochemical stability 
is of immense interest to the pharmaceutical industry due to the unwanted consequences of 
protein structural changes, increased immunogenicity, and potential inactivation. In the 
biotechnology industry, proteins have the potential to be exposed to ambient light during all 
phases of development. The most photosensitive amino acids, Trp and Cys, have been studied 
thoroughly, but little is known about their combined photochemistry in proteins. It is important 
to study such interactions because many relevant biopharmaceuticals, like antibodies, contain 
multiple disulfides and Trp.  
 The aim of this dissertation project was to further investigate protein stability in proteins 
and model peptides containing Trp and/or disulfide bonds to help elucidate novel mechanisms of 
protein degradation to lead to a greater understanding of protein stability. With this knowledge, 
better formulation of antibodies can be developed, and faster progression through the drug 
development stages could lead to more stable antibodies on the market. 
 
Chapter 2 investigates the extent of H-atom transfer reactions between thiyl radicals and 
neighboring amino acid residues using a model peptide with sterically demanding Val amino 




Chapter 3 aims to elucidate the mechanism of Trp side chain cleavage in the presence of a 
disulfide with an IgG1 molecule and several Trp and disulfide containing model peptides.  
 
Chapter 4 evaluates His oxidation in an IgG1 molecule and model peptides, and describes a Trp 
side chain cleavage reaction without the presence of a disulfide in Trp-containing model 
peptides. 
 
Chapter 5 summarizes the findings and conclusions of this dissertation and discusses the 
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Chapter 2. Photodegradation of valine and disulfide-containing model peptides: 















2.1 Introduction   
The superior specificity and efficiency has boosted the development of protein 
pharmaceuticals.1,2 However, proteins are susceptible to chemical and physical degradation that 
can result in loss of potency or cause immunogenicity.3,4,5,6,7 Therefore, the evaluation of protein 
stability is paramount to the development of protein pharmaceuticals. Stability studies are also 
becoming increasingly important to demonstrate likeness between follow-on biologics 
(biosimilars) and their original counterparts (innovator drugs).8 One important area of concern is 
photostability, as proteins are exposed to light during production, purification, formulation and 
storage.9,10     
 In proteins, the amino acids most susceptible to light stress are the aromatic amino acids, 
Trp, Tyr, and Phe, and the disulfide bond.9 The absorption of light by aromatic amino acids 
generates an excited singlet state, which can fluoresce, undergo intersystem crossing to the first 
excited triplet state, or eject an electron into solution, resulting in a solvated electron and an 
aromatic radical cation.11,12,13,14,15 In case of Trp, Trp radicals or triplet Trp can react with 
oxygen to form the photosensitizing products N-formyl kynurenine and kynurenine,16,11,12, 17,18,19 
amino acid peroxy radicals,20,21 or other reactive oxygen species. These products can promote 
additional oxidation reactions in the protein solution.  
 Triplet Trp or the solvated electron can reduce the disulfide bond to a disulfide radical 
anion, and following proton addition and cleavage, generate a thiol and a thiyl radical.22,23,24 
Thiyl radicals can also be generated directly by homolytic cleavage of a disulfide bond following 
photo-irradiation.25 Especially in the case of Cys disulfide bonds, the homolytic cleavage 
generates predominantly thiyl radicals while perthiyl radicals are a major product of the 
homolytic cleavage of penicillamine disulfide.26 Subsequently, thiyl radicals can recombine to 
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disulfide bonds,27 native or scrambled, disproportionate into thiol and thioaldehyde,28 and/or 
generate thioether and dithiohemiacetal products.29 The later products were observed first in 
model peptides upon UV light exposure, and subsequently detected in IgG1 after exposure to 
similar light stress.30 Under aerobic conditions, thiyl radicals reversibly add oxygen to form thiyl 
peroxyl radicals,31 which ultimately convert into sulfinic, sulfenic, or sulfonic acids.32,33 These 
oxidation products are also formed non-photolytically in alkaline conditions.34,35 Additional non-
photolytic disulfide degradation pathways under alkaline conditions include disulfide 
scrambling36 and β-elimination.37 β-Elimination leads to the formation of dehydroalanine, which 
can subsequently cross-link with nucleophiles such as thiols and amines.38 
 Protein and peptide thiyl radicals may involve in reversible, intramolecular hydrogen 
atom (H-atom) abstraction reactions from nearby αC-H or side chain C-H bonds generating 
intermediary C-centered radicals.28,29,39,40 Scheme 2.1 shows the pathway to form such C-
centered radicals, using covalent H/D exchange to monitor where Deuterium incorporation is 
observed by mass spectrometry. C-centered radicals may subsequently involve in oxidation, 
cross-linking or fragmentation pathways.41 Especially with αC-H bonds, such reversible H-atom 
transfer processes may induce epimerization.42,43,44  
Scheme 2.1. Reaction for covalent H/D exchange between the thiyl radical and βC-H. 
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 To evaluate the reactivity of Cys thiyl radicals and their propensity for reversible, 
intramolecular H-atom abstraction from nearby amino acids, Cys thiyl radicals were generated 
photolytically from a series of model disulfide peptides. In these peptides, various aliphatic 
amino acids were placed in the i+1 and i-1 position relative to the disulfide bond.39,40,28-29 
Evidence for reversible intramolecular H-atom transfer reactions was obtained through covalent 
H/D exchange (Scheme 2.1).28 Interestingly, H-atom transfer was most efficient for reactions of 
Cys thiyl radicals with Gly in i-1 and i+1 in the peptide GGCGGL.28 When Cys thiyl radicals 
were generated in peptides containing Ala at positions i-1 and i+1, i.e., in the peptide 
(LGACAGL)2, H-atom transfer proceeded not only from the 
αC-H bond but also the side chain 
C-H bond from Ala. Moreover, L-Ala was efficiently converted into D-Ala and additional 
products were observed, such as dehydroalanine (Dha).  
 These results motivated us to evaluate the reactions of Cys thiyl radicals with larger, 
sterically more demanding amino acids such as Val. To this end, we synthesized the disulfide-
containing peptides (LGVCVGL)2, in which the Val residues displayed the natural C- and N-
isotope distribution (i.e., 98.9% 12C and 99.6% 15N) or were uniformly 13C-labeled (97-99%) and 
15N-labeled (97-99%) at either the i+1 or the i-1 position. Complementary experiments were 
performed with Cys thiyl radicals generated from the Cys-containing model peptide LGVCVGL. 
Our results will demonstrate that Cys thiyl radicals react with the Val residues, but also enter a 
pathway which yields a new reaction product, tentatively identified as isothiazole-3(2H)-one. 
The formation of this product is likely the result of steric constraints, which disfavor 
intermolecular reactions of thiyl radicals, since previous studies with (LGACAGL)2 and 
(GGCGGL)2 showed no significant yields of such product. These reactions are highly relevant 
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for degradation pathways of protein therapeutics, where disulfide bonds are subject to 
photodegradation.  
2.2 Experimental methods 
 2.2.1 Materials. Ammonium bicarbonate (NH4HCO3), 2,2'-azobis-2-methyl-
propanimidamide, dihydrochloride (AAPH), N-ethylmaleimide (NEM), dimethyl sulfoxide, β-
mercaptoethanol (BME), thioanisole, 1,2 ethanedithiole (EDT), and anisole were supplied by 
Sigma-Aldrich (St. Louis, MO) at the highest commercially available purity. Methanol, 
dichloromethane, acetonitrile, and trifluoroacetic acid were supplied by Fisher Scientific 
(Pittsburg, PA). Deuterium oxide (D2O, 99.9%) and stable isotope-labeled L-Valine-N-Fmoc 
(Valine U-13C5, 97-99%, 
15N, 97-99%) were purchased from Cambridge Isotope Laboratories 
(Andover, MA, USA). The U-13C5 notation indicates that all five carbon atoms of L-Val in the 
isotope-labeled L-Valine-N-Fmoc are 13C-labeled, and the 15N notion indicates 15N-labeling of 
the amide bond (Chart 1). Fmoc-L-Ala, Fmoc-L-Val, Fmoc-L-Gly, Fmoc-L-Cys-trt, and Fmoc-
L-Leu were supplied by Novabiochem (Darmstadt, Germany), and Fmoc-L-Leu-PEG-PS was 
supplied by Applied Biosystems (Foster City, CA). O-(7-Azabenzotriazole-1-yl)-N, N,N’N’-
tetramethyluronium hexafluorophosphate (HATU) was supplied by GenScript Corporation 
(Piscataway, NJ). 
 2.2.2 Peptide Synthesis. The model peptide (LGVCVGL)2 (1a), and its stable isotope-
labeled derivatives (LGV[U-13C5, 
15N]CVGL)2 (1b) , and (LGVCV[U-
13C5, 
15N]GL)2 (1c) (Chart 
2.1) were synthesized from their respective linear Cys-containing  peptides (of the general 
structure 1d). The linear peptides were synthesized using solid phase Fmoc-chemistry on a 
PioneerTM Peptide Synthesis System. Following the synthesis, the crude material was washed 
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with methanol and dichloromethane. The thiol was deprotected and the peptide was cleaved from 
the resin using reagent R (TFA, thioanisole, EDT, and anisole at a ratio of 90%:5%:3%:2% 
(v:v:v)) as described in detail elsewhere.45 Peptides 1d were purified from the crude mixture by 
HPLC using a YMC-Pack ODS-A semipreparative C18 column with dimensions of 250 x 20 
mm ID containing 5 µm particles (YMC America, Inc. Allentown, PA), with a 5 ml min-1 flow 
rate. Mobile phases consisted of water, acetonitrile, and trifluoroacetic acid at a ratio of 
90%:10%:0.1% (v:v:v) for solvent A and a ratio of 10%:90%:0.1% (v:v:v) for solvent B. A 
linear gradient was developed from 10% to 90% B within 30 min. Following lyophilization, the 
purified thiol peptides were reconstituted for oxidation to 1 mg/mL in a solution of 50 mM 
ammonium bicarbonate buffer containing 20% dimethyl sulfoxide at pH 7.8. The oxidation 
reaction was allowed to proceed at room temperature, open to air, for four hours to form peptides 





1a, 1b, and 1c.46 The disulfide peptides were then purified using the semipreparative C18 
column and lyophilized prior to experimentation. 
 2.2.3 UV Irradiation of Model Peptides. Peptides 1a, 1b, and 1c (Chart 2.1) were 
dissolved in water at pH 4.0 or 7.0 to a concentration of either 100 nM or 100 µM. The solutions 
were Ar-saturated through head-space equilibration with Ar for thirty minutes in quartz tubes 
capped with rubber stoppers. The solutions were then irradiated at λ = 254 nm (flux of 2.96 x 10-
4 einstein.min-1,  measured by actinometry) for up to ten minutes in a Rayonet photoreactor 
equipped with 4 lamps (Southern New England, Branford, CT, RMA-500) at room temperature. 
Directly after photolysis, samples were either derivatized with N-ethylmaleimide (NEM) or beta-
mercaptoethanol (BME) or frozen at -20 °C until mass spectrometry analysis. Free thiols were 
derivatized with 1.8 mM NEM for one hour at 37˚C and one hour at room temperature in 50 mM 
ammonium bicarbonate buffer, pH 7.8. The free amines were also derivatized with NEM at this 
pH because amine derivatization is favorable at pH > 7.0.47 To separate samples, α,β-unsaturated 
carbonyl  products were reacted with 10 mM BME for two hours at room temperature in 50 mM 
ammonium bicarbonate buffer, pH 7.8.48,49  
 2.2.4 AAPH Reaction with Peptide 1d. Cys thiyl radicals were generated via reaction of 
peptide 1d with carbon-centered radicals generated from the thermal decomposition of AAPH.50 
Peptide 1d (Chart 2.1) was dissolved in 50 mM sodium phosphate buffer at a range of pH values 
from 6.0-10.0 at a concentration of 100 µM.51 Peptide solutions were placed in glass tubes, 
capped with rubber stoppers, and saturated with Ar for 30 minutes. Similarly, a solution of 10 
mM AAPH in pH 7.0, 50 mM sodium phosphate buffer was placed on ice and also saturated 
with Ar in a glass tube with a rubber stopper for 30 minutes. Following saturation, a final 
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concentration of 1 mM AAPH was added to the peptide samples under the Ar environment and 
incubated for 1 hour at 37 °C, generating 4.9x10-6 M AAPH-derived radicals.    
 2.2.5 LTQ-FT Mass Spectrometry Analysis. For higher sensitivity of product 
characterization, the peptides were analyzed on a linear trap quadrupole-Fourier transform (LTQ-
FT) ion cyclotron resonance mass spectrometer (Thermo-Finnigan, Bremen, Germany) 
combined with an NanoAcquity UPLC System (Waters Corp., Milford, MA, USA). The 
instrument was operated in a data-dependent acquisition mode with all lenses optimized on the 
MH+ ion from leucine enkephalin. The ESI source was operated with a spray voltage of 2.8 kV, 
a tube lens offset of 96 V and a capillary temperature of 200 °C. The peptides were eluted from a 
reverse phase non-porous Imtakt Presto FF-C18 column with dimensions of 15 cm x 0.5 mm ID, 
containing 2 µm particles (Imtakt Corp., Philadelphia, PA, USA), at a flow rate of 5 µL min-1. 
The mobile phases consisted of H2O, acetonitrile, and formic acid at a ratio of 99.9%:0%:0.1% 
(v:v:v) for solvent A and a ratio of 0%:99.9%:0.1% (v:v:v) for solvent B. A linear gradient was 
developed from 3% to 40% B within 50 minutes. The XCalibur software was used to acquire and 
analyze the data.  
 2.2.6 Q-tof Mass Spectrometry Analysis. Peptides and photoproducts were analyzed on 
a Micromass Q-Tof Premier mass spectrometer (Micromass Ltd., Manchester, U.K.) combined 
with an Acquity UPLC System (Waters Corp., Milford, MA, USA). The instrument was operated 
in the MSE mode with all lenses optimized on the MH+ ion from sodium iodide. The ESI source 
was operated with a spray voltage of 2.5 kV, a tube lens offset of 75 V and a capillary 
temperature of 250 °C. The peptides were eluted from a Grace reverse phase capillary C18 
column with dimensions of 25 cm x 0.5 mm containing 5 μm particles (Fisher Scientific, 
Pittsburg, PA), at a flow rate of 20 µL min-1. The mobile phases consisted of H2O, acetonitrile, 
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and formic acid at a ratio of 99.9%:0%:0.1% (v:v:v) for solvent A and a ratio of 0%:99.9%:0.1% 
(v:v:v) for solvent B. A linear gradient was developed from 15% to 50% B in 43 minutes. 
MassLynx software was used to acquire and analyze the data. 
  2.2.7 1H-NMR. 1H-NMR spectra were recorded on a Bruker Avance 400 MHz NMR 
instrument, equipped with a X-channel observe quadrupole nuclei probe. Peptide 1d was 
dissolved to a concentration of 50 µM in 50 mM sodium phosphate buffer at pH 9.0,51 and 10 
mM AAPH was dissolved in 50 mM sodium phosphate buffer at pH 7.0 and placed on ice. Both 
solutions were placed in glass tubes, capped with rubber stoppers, and saturated with Ar for 30 
minutes. Following saturation, a final concentration of 1 mM AAPH was added to the sample 
under Ar and incubated for 1 hour at 37 °C.  The sample was left at room temperature for 2 days 
before being concentrated to dryness in a CentriVap concentrator and re-diluted with D2O at pD 
3.0. Then, 600 µL each of the sample and two controls (unreacted peptide 1d and AAPH in the 
absence of peptide 1d, respectively) were placed in NMR tubes (Wilmad LabGlass, Vineland, 
NJ) for NMR analysis. 1H-NMR spectra were generated using 1024 scans and a pulse width of 
14.25 seconds. Chemical shifts were predicted in ChemBioDraw Ultra 13.0 (Perkin Elmer, 
Waltham, MA) and an online NMR predictor program developed  at the Ecole Polytechnique 
Fédérale de Lausanne (EPFL).52 NMR data were analyzed using MestReNova version 9.0 
(Mestrelab Research, Santiago de Compostela, Spain). 
 2.2.8 1H-1H TOCSY (Total COrrelation SpectroscopY) NMR. 1H-1H TOCSY NMR 
spectra were recorded on a Bruker Avance 800 MHz NMR instrument, equipped with a TCI 
cryoprobe. Peptide 1a was dissolved to a concentration of 100 µM and Ar-saturated through 
head-space equilibration with Ar for thirty minutes in quartz tubes capped with rubber stoppers. 
The solution was then irradiated at λ = 254 nm and frozen at -20 °C until further analysis. Then, 
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600 µL of irradiated peptide 1a and control (non-irradiated) peptide 1a were placed in NMR 
tubes (Wilmad LabGlass, Vineland, NJ) for NMR analysis. 1H-1H TOCSY NMR spectra were 
generated with a mixing time of 80 msec. Chemical shifts were predicted in ChemBioDraw Ultra 
13.0 (Perkin Elmer, Waltham, MA). NMR data were analyzed using MestReNova version 9.0 
(Mestrelab Research, Santiago de Compostela, Spain). 
 2.2.9 1H-13C HSQC (Heteronuclear Single Quantum Coherence) NMR. 1H-13C 
HSQC NMR spectra were recorded on a Bruker Avance 800 MHz NMR instrument, equipped 
with a TCI cryoprobe. Peptides 1b and 1c were dissolved to a concentration of 100 µM and Ar-
saturated through head-space equilibration with Ar for thirty minutes in quartz tubes capped with 
rubber stoppers. The solutions were then irradiated at λ = 254 nm and frozen at -20 °C until 
further analysis. Then, 600 µL of irradiated peptide 1b, 1c and control (non-irradiated) peptide 
1a and 1b were placed in NMR tubes (Wilmad LabGlass, Vineland, NJ) and 1H-13C HSQC 
NMR spectra was acquired. Chemical shifts were predicted in ChemBioDraw Ultra 13.0 (Perkin 
Elmer, Waltham, MA). NMR data were analyzed using MestReNova version 9.0 (Mestrelab 
Research, Santiago de Compostela, Spain). 
2.2.10 Ozonolysis Reaction with Peptide 1a Photoproducts. Peptide 1a was dissolved 
in water at pH 7.0 to a concentration of 100 µM, Ar-saturated, and irradiated at λ = 254 nm for 
ten minutes. Directly after photolysis, samples were frozen at -20 °C until ozonolysis. Ozone 
(O3) was generated using an ozonolysis apparatus (Ozotech, Inc., Yreka, CA). The O3 was then 
bubbled directly into the samples for 30 seconds at room temperature or bubbled into water for 2 
minutes, and then the O3-containing water was added to the samples. Directly after the 
ozonolysis reactions were completed, 0.1 M sodium borohydride was added to the samples and 
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reacted at room temperature for 30 minutes. The samples were then frozen at -20 °C until MS 
analysis.  
2.3. Results   
 2.3.1 Photo-irradiation of 100 nM Peptide 1a at pH 7.0. Peptide 1a (Chart 2.1) was 
dissolved in water to a concentration of 100 nM at pH 7.0. Solutions of 100 uL were exposed to 
light at λ = 254 nm at room temperature for up to 10 minutes in quartz tubes following Ar -
saturation. The resultant photoproducts of peptide 1a were then analyzed by LC-MS using the Q-
tof Premier (Figure 2.1) and MS/MS using the LTQ-FT instrument. No traces of products were 
observed in non-irradiated control samples (Figure 2.1A). However, after 1 minute of irradiation 
Figure 2.1 LC-MS analysis of the photoproducts generated by UV-irradiation at λ = 254 nm of peptide 1a (100 nM) in 
Ar-saturated H2O,  pH 7.0:  (A) no irradiation (control); (B) 30 seconds of irradiation; (C) 1 minute of irradiation. 
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(Figure 2.1C), peptide 1a was completely 
degraded to one major photoproduct and 
three minor photoproducts. A tentative 
structure of product 2a (m/z 656.4) is 
displayed in the chromatogram in Figure 
2.1C and in Table 2.1. Table 2.1 also 
shows an alternative structure for product 
2a, the isobaric structure 2b (m/z 656.4), 
and the structures for the minor 
photoproducts formed: 3 (m/z 660.4), 4 
(m/z 626.4), and 5 (m/z 642.4). Mass 
spectrometry, NMR analysis and chemical derivatization were used to assign structures to the 
photoproducts, as will be described in the following sections.  
 i. Product 2a (m/z 656.4). After just 30 seconds of UV irradiation (Figure 2.1B), 60% of 
peptide 1a were converted into product 2a. Following one minute of irradiation (Figure 2.1C), 
90% of peptide 1a were converted to product 2a, which was still the major photoproduct after  
10 minutes of irradiation, albeit at a 35% yield because of the increase in yields of the other 
photoproducts (LC-chromatogram and table of photoproducts presented in Appendix A, Figure 
A.1 and Table A.1). Product 2a was quantified via peak area of the chromatographic peak 
relative to the peak area of peptide 1a (assuming similar response factors). The m/z value of 
product 2a reveals a loss of 4 Da compared with peptide 1d, i.e. the reduced, Cys-containing half 
of the original disulfide-containing peptide 1a. By MS/MS analysis, the loss of 4 Da is localized 
to the Cys residue of the peptide, highlighted by the b3 and b4 ions in the fragmentation scheme 
Table 2.1. Peptide 1a photoproducts observed after photolysis 
at λ = 254 nm. 
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displayed in Figure 2.2. On the other hand, the y4, y5, and y6 ions clearly show that the N-
terminal LGV moiety of the peptide is unaltered. Likewise, the b5 and b6 ions reveal that the C-
terminal GL moiety is unaltered. Lower molecular weight ions (i.e. b1, b2, y1, and y2) are 
frequently not observed in the LTQ-MS data because of the m/z cutoff between 170-200 Da. At 
this point, we tentatively assign to product 2a the structure of an isothiazol-3(2H)-one, which 
contains an S-N bond in combination with a double bond between the αC-βC bond of the original 
Cys residue. However, based on the mass spectrometry data alone we cannot exclude the 
possibility of an S-O bond such as shown in product 2b. A clear distinction between both 
structures was subsequently achieved by 1H-NMR experiments, as described in section 2.3.8 (see 
Figure 2.2. MS/MS spectrum of product 2a after UV irradiation at λ = 254 nm of peptide 1a at pH 7.0 (100 nM) in an 
Ar-saturated H2O. C* corresponds to the modified Cys sulfenamide structure.  
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below). The highest 
intensity fragment 
observed during MS/MS 
analysis of product 2a is  
that of [M+H]+1-18, i.e. of 
the molecular ion, which 
has lost one water 
molecule. Instead, the 
intensities of the 
remainder ions is between 
5-15% compared to that of 
[M+H]+1-18. Notably, the MS/MS lack any ions which display a loss of 34 Da, i.e. of H2S, 
consistent with the lack of a free thiol. Importantly, the sulfenamide structure is consistent with 
the formation of the b4 ion, as it has been shown that the S-N bond in cyclic sulfenamides can be 
cleaved via gas phase fragmentation.53 In the literature, the ESI fragmentation of a cyclic 
sulfenamide, sulfinamide, and sulfonamide formed between neighboring Lys and Cys residues in 
the peptide PFKCG reported the b and y ions consistent with a loss of 2 Da on the Cys residue 
(combined with oxidation in the case of sulfinamide and sulfonamide) through the cleavage of 
the S-N bond.  
 ii. Product 3 (m/z 660.4). The disproportionation of thiyl radicals leads to thiol and 
thioaldehyde, as documented for the photo-irradiation of (GGCGGL)2
28 and (LGACAGL)2.
40 
Product 3 is structurally identical to peptide 1d and accounts for 7% of the total products after 30 
seconds of photo-irradiation (Figure 2.1B). The MS/MS spectrum (Figure 2.3) clearly shows all 
Figure 2.3. MS/MS spectrum of product 3 after UV irradiation at λ = 254 nm of 
peptide 1a at pH 7.0 (100 nM) in an Ar-saturated H2O. 
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the y and b ions which 
are consistent with the 
reduction of the disulfide 
to the thiol. Specifically, 
b3, b4, y3, and y4 
confirm the presence of 
reduced Cys. The relative 
intensities of the 
fragment ions of this 
product are much more 
evenly distributed among 
all the product ions. The 
b5 ion is the most intense 
ion, but the ion generated 
from the loss of water by 
dehydration of the C-
terminal, the b4, a5, and 
b6 ions are also intense.  
 iii. Product 4 (m/z 
626.4). Product 4 
contains a 
dehydroalanine (Dha) 
residue in place of the 
Figure 2.4. MS/MS spectrum of product 4 after UV irradiation at λ = 254 nm of 
peptide 1a at pH 7.0 (100 nM) in an Ar-saturated H2O. 
Figure 2.5. MS/MS spectrum of product 5 after UV irradiation at λ = 254 nm of 
peptide 1a at pH 7.0 (100 nM) in an Ar-saturated H2O. C^ corresponds to the 
modified Cys aldehyde structure. 
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original Cys residue. This product 
also accounts for 7% of the total 
products formed after 30 seconds 
of irradiation (Figure 2.1B). The 
formation of Dha had been earlier 
characterized for the photo-
irradiation of (LGACAGL)2.
40 The 
MS/MS spectrum (Figure 2.4) of 
this product reveals is consistent 
with Dha formation, where the b3, 
b4, b5 and y3, y4, and y5 ions 
localize the Dha residue to the 
original position of Cys. 
 iv. Product 5 (m/z 642.4). Figure 2.1B shows trace amounts of product 5 after 1 minute of 
photo-irradiation. The MS/MS spectrum (Figure 2.5) is consistent with the formation of an 
aldehyde at the original Cys residue, generated through hydrolysis of a thioaldehyde, the other 
disproportionation product of Cys thiyl radicals.28 This product is formed through the oxidation 
of the thioaldehyde, the other disproportionation product besides the thiol. 
 2.3.2 Derivatization of Photoproducts with N-ethylmaleimide (NEM).  Further 
product identification following 10 minutes of irradiation of 100 nM peptide 1a at pH 7.0 was 
achieved by derivatization with NEM. For this, an aliquot of the sample was removed and a final 
concentration of 1.8 mM NEM was added. The pH was then adjusted to pH 7.8 with 50 mM 
ammonium bicarbonate buffer, amenable for both derivatization of free thiols and amines.47 MS 
Table 2.2. Peptide 1a photoproducts derivatized with NEM. 
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analysis was performed 
on the LTQ-FT 
instrument. Table 2.2 
shows the products 
detected after NEM 
derivatization. Products 
2a+NEM (m/z 781.4), 
4+NEM (m/z 751.4), 
and 5+NEM (m/z 
767.4) had NEM added 
to the N-terminal amine 
while product 3+NEM 
(m/z 785.4) had NEM 
added to the thiol. 
 i. Product 2a+NEM 
(m/z 781.4). Table 2.2 




confirms the addition of 
NEM to the N-terminal 
amino group (Figure 
Figure 2.6. MS/MS spectrum of product 2a derivatized with NEM. C* corresponds 
to the modified Cys sulfenamide structure. 
Figure 2.7. MS/MS spectrum of product 3 derivatized with NEM.  
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2.6). Neither of the y ions 
shows NEM addition while 
the b2 ion and subsequent b 
ions display the expected 
addition of 125 Da 
consistent with NEM 
addition to the N-terminal 
amino group. The ion 
intensities in this MS/MS 
spectrum are comparable to 
those of the non-
derivatized product 2a (Figure 2), except for the 125 Da mass change of the b-ions.  
 ii. Product 3+NEM (m/z 785.4). As anticipated, product 3 is derivatized by NEM on the 
Cys moiety (Table 2.2). The ions b3, b4, y3, and y4 in the MS/MS spectrum localize the NEM 
addition to the Cys residue (Figure 2.7).   
 iii. Product 4+NEM (m/z 751.4). The only nucleophile in product 4 amenable for 
reaction with NEM is the N-terminal amino group, and the MS/MS spectrum confirms the 
addition of  NEM to the amino group in product 4+NEM (Figure 2.8); the b2 ion of product 
4+NEM  shows an increase by 125 Da compared to product 4, and the remainder of the b ions 
support this derivatization. In contrast, the y-ion series does not display any increase by 125 Da. 
 iv. Product 5+NEM (m/z 767.4).The MS/MS spectrum of product 5+NEM indicates the 
addition of NEM to the N-terminal amine (Figure 2.9).  
Figure 2.8. MS/MS spectrum of product 4 derivatized with NEM.  
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 2.3.3 Derivatization of 
Photoproducts from 100nM 
Peptide 1a at pH 7.0 with β-
mercaptoethanol (BME). To 
localize α,β-unsaturated 
carbonyls, such as 
dehydroalanine, and the 
proposed S-N bond, a final 
concentration of 10 mM BME 
was added following 10 minutes 
photo-irradiation of 100nM 
peptide 1a, pH 7.0. The pH was 
adjusted to pH 7.8 with 50 mM 
ammonium bicarbonate buffer, 
to shift the equilibrium toward 
the nucleophilic thiolate species. 
LC-MS/MS analysis was 
performed on the LTQ-FT 
instrument. Table 2.3 displays 
the products that formed after reaction with BME and the structures assigned to these products: 
product 2a+BME (734.4), product 2a+2BME (m/z 812.4), and product 4+BME (m/z 704.4). 
Scheme 2.2 shows how product 2a can be derivatized twice with BME: once through the 
cleavage of the S-N bond, and once to the double bond.  
Figure 2.9. MS/MS spectrum of product 5 derivatized with NEM.  
Table 2.3. Peptide 1a photoproducts derivatized with BME.  
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 i. Product 2a+BME 
(m/z 734.4). MS analysis 
revealed a product from the 
addition of a single BME 
molecule to product 2a.54,55 
Figure 2.10 shows the 
MS/MS spectrum, where 
the b3, b4 and y4 fragment 
ions indicate single BME 
derivatization on the Cys 
group.  The b4, b5, and b6 
fragments reveal that the C-terminal sequence VGL is unmodified, and the y4, y5, and y6 
fragments reveal that the N-terminal sequence LGV is unmodified. The intensities of the 
fragment ions is different following BME addition to 2a as compared to the precursor product 2a 
(Figure 2.2). The most abundant ions are now the b5 and b6 ions. Interestingly, the b4 ion, which 
Scheme 2.2. Reaction of product 2a with BME.  
Figure 2.10. MS/MS spectrum of product 2a mono-derivatized with BME. 
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must cleave the heterocyclic 
cross-link to undergo gas-
phase fragmentation in 
product 2a, is now much 
more intense after BME 
addition, which leads to 
chemical cleavage of the S-N 
bond prior to MS analysis 
(Scheme 2.2, reaction 6 and 
7). Therefore, intensity of the 
b4 ion in Figure 2.2 is only 
about 15%, whereas the 
intensity of the b4 ion in 
Figure 2.10 is ca. 50%. 
Additionally, in the MS/MS 
spectrum of 2a+BME we 
observe ions corresponding 
to the loss of BME, a 
common fragmentation 
product.  
 ii. Product 2a+2BME (m/z 812.4). In addition to mono-derivatization, we observe a 
product revealing the addition of two molecules BME to product 2a. The MS/MS spectrum of 
2a+2BME (Figure 2.11) reveals that these two BME molecules are added to the original Cys 
Figure 2.11. MS/MS spectrum of product 2a di-derivatized with BME. 
Figure 2.12. MS/MS of product 4 derivatized with BME. 
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residue. Specifically, the b3, b4, y3, and y4 ions localize the addition of 156 Da to the original 
Cys residue, consistent with Scheme 2.2. Many of the large fragments in the MS/MS spectrum 
show a loss of 1 or 2 BME molecules from the parent ion during gas phase ionization.  
 iii. Product 4+BME (m/z 704.4). The MS/MS spectrum of product 4+BME, and 
especially the b3, b4, y3 and y4 ions, is consistent with a Michael addition of BME to Dha 
produced from Cys (Figure 2.12). 
 2.3.4 Isothiazole-3(2H)-one Formation in Peptides 1a, 1b, and 1c at pH 7.0. We 
synthesized stable isotope-labeled peptides 1b and 1c in order to unambiguously locate the cyclic 
sulfenamide by means of isotopic substitution of the mass spectrometric fragment ions. Peptides 
1a, 1b or 1c were dissolved in water to a concentration of 100 µM at pH 7.0. Solutions of 100 uL 
were then exposed to light at λ = 254 nm for ten minutes in quartz tubes at room temperature 
after Ar-saturation. The resultant photoproducts from all three peptides were then analyzed by 
LC-MS on the Qtof Premier instrument. Figure 2.13 shows representative chromatograms 
recorded for the control 
(Figure 2.13A) and photo-
irradiated peptide 1a after 
ten minutes (Figure 2.13B). 
The sulfenamide product 2a 
is the main product also 
under these experimental 
conditions; however, a 
number of additional 
products are generated as 
Figure 2.13.  LC-MS analysis of the photoproducts generated by UV-irradiation 
at λ = 254 nm of peptide 1a (100 µM) in Ar-saturated H2O at pH 7.0 in the (A) 
control and (B) the sample after 10 minutes of irradiation. 
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well. These products, together 
with their MS and MS/MS 
data and tentative structural 
assignments are detailed in 
described in Section 2.3.9 
(below). Our current focus is 
on product 2a, which displays 
m/z 656.4 when generated 
from peptide 1a, and as 
expected, m/z 662.4 for 
products 9 and 10 (Table 
2.4), when generated from 
peptides 1b and 1c, 
respectively, due to the 
presence of 13C and 15N in 
one of the two Val residues. 
All the resultant 
photoproducts from peptide 
1d were analyzed on the LTQ-FT instrument in the M/MS and MS3 modes. However, product 9 
and 10 were purified by HPLC, and the purified products were analyzed on the LTQ-FT 
instrument in the MS/MS and MS3 modes. The MS/MS data of product 2a will not be described 
in detail here, as the MS/MS spectrum and results were described in Section 2.3.1.  
Table 2.4. Peptide 1b and 1c sulfenamide photoproducts observed after 10 
minutes of photolysis at λ = 254 nm. The 13C and 15N labeled amino acids are 
indicated in bold font. 
Figure 2.14. MS/MS spectrum of product 9 after UV irradiation at 254 nm. 
The 13C and 15N labeled amino acids are indicated in bold font, and the C* 
corresponds to the modified Cys sulfenamide structure. 
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 i. Product 9 (m/z 662.4). Following the irradiation of peptide 1b, product 9 was generated 
as a major photoproduct (Table 2.4). The m/z value of product 9 (m/z 666.4; Figure 2.14) shows 
a loss of 4 Da compared to the reduced Cys-containing derivative of peptide 1b. As expected, 
product 9 eluted chromatographically exactly where product 2a eluted. The MS/MS 
fragmentation of product 9 shows the same fragment ions as product 2a, except for a mass shift 
of 6 Da for fragments containing the stable isotope-labeled C-terminal Val residue. For instance, 
while the b3 and b4 ions display m/z 270.1 and m/z 369.3, identical to the MS/MS data of 
product 2a (Figure 2.2), the higher b ions and the y3 ions and higher show an increase of 6 Da 
compared to that of product 2a. Product 9 shows a fragmentation profile comparable to product 
2a: the y4, y5, and y6 ions clearly show that the N-terminal LGV sequence of the peptide is 
unaltered and the b5 and b 6 ions show that the C-terminal GL sequence is unaltered. 
Importantly, there is a loss of 4 Da from the original Cys residue of the peptide, highlighted by 
the b3 and b4 ions. 
 ii. Product 10 (m/z 662.4). 
Photo-irradiation of Peptide 
1c generated product 10 
(Table 2.4) as a major 
photoproduct. Product 10 
(m/z 662.4; Figure 2.15) 
shows a loss of 4 Da 
compared to the reduced Cys-
containing form of peptide 
1c. Product 10 co-eluted with 
Figure 2.15. MS/MS spectrum of product 10 after UV irradiation at 254 nm. 
The 13C and 15N labeled amino acids are indicated in bold font, and the C* 
corresponds to the modified Cys sulfenamide structure. 
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products 2a and 9. However, the MS/MS spectra of products 9 and 10 differ. The MS/MS 
spectrum of product 10 displays a y4 ion (m/z 387.0), similar to that of product 2a, but a y5 ion 
(m/z 492.3) which is 6 Da heavier as compared to the y5 ion of product 2a. The b ions show an 
increase in 6 Da compared to product 2a. These data are, again, consistent with a modification of 
the Cys residue and a cyclic sulfenamide, highlighted by the b3 and b4 ions. The y4, y5, and y6 
ions show that the N-terminal LGV sequence of the peptide is unaltered and the b5 and b6 ions 
show that the C-terminal GL sequence is unaltered.  
 2.3.5 MS3 Fragmentation of Products 2a, 9, and 10. To further characterize the 
structures of products 2a, 9, and 10, MS3 experiments were performed on the respective b3, b4 
and VC*V (where C* indicated the modified Cys sulfenamide structure) fragment ions extracted 
from the MS/MS data in Figures 2.2, 2.14, and 2.15, respectively. Other than isotopic mass 
differences between the fragments, the fragmentation profiles look generally similar, as expected 
for three identical products which only differ in the isotopic distributions on one of the Val 
residues. The MS3 data, especially those for MS3 of the internal fragment VC*V, support the 
structures of products 2a, 9 and 10 and illustrate that only the Cys and the Val residue C-terminal 
to Cys are involved in sulfenamide formation. In addition, the distribution of isotopes in the MS3 
fragment ions allows us to assign fragmentation pathways (see Discussion).  
 i. b3 fragment ions (m/z 270.2, 270.2, and 276.2 for products 2a, 9, and 10, respectively). 
Figure 2.16 displays the MS3 spectrum of the b3 ion from products 2a (m/z 270.3), 9 (m/z 
270.3), and 10 (m/z 276.3). In product 10 the isotopically labeled Val residue is located N-
terminal to Cys, rendering the m/z value of the b3 ion 6 Da higher compared to the b3 ions from 
products 2a and 9. Figure 2.16A shows the MS3 fragmentation of the b3 ion from product 2a 
(m/z 270.3). All the ions seen in these spectra are common neutral losses indicative of a linear 
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peptide with no modifications or internal cyclization. The ion with the highest intensity is the b2 
ion (m/z 171.06) (a mechanistic scheme for the fragmentation pathways will be provided in the 
Discussion). The b2 ion is written in a linear fashion, although we acknowledge it could be 
cyclic with the N-terminal, but it has been displayed in this way for clarity. There are also 
moderately intense peaks for neutral losses of water (m/z 252.36), and CO (m/z 241.98) from b3, 
Figure 2.16. MS3 fragmentation of the b3 ion from the MS/MS spectra of (A) product 2a; (B) product 9; (C) product 
10. The 13C and 15N labeled amino acids are indicated in bold font and with *C/N. 
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and combined losses of CO and either water (m/z 224.20) or ammonia (m/z 225.1) from b3, 
respectively. The a1 ion (m/z 85.96) and x1 ion (m/z 142.93) are also identifiable peaks in the 
spectrum. The m/z 199.16 ion could not be identified, although it could be interesting as product 
10 has a peak with m/z 207.12 (Figure 2.16C). Figure 2.16B shows the MS3 spectrum of the b3 
ion from product 9 (m/z 270.3). This spectrum is slightly different than the other two, 
unexpected since we assume this fragment is structurally identical to the b3 ion of 2a and 10. 
The difference could be related to lower ionization energy in the FT-MS in this single 
experiment. The ion of highest intensity is the fragment ion generated by a combined loss of CO 
and water from b3 in of highest intensity (m/z 224.1). Other observed ions are the b2 ion (m/z 
171.1), and ions derived from the neutral loss of water (m/z 252.4), the combined loss of CO and 
ammonia (m/z 225.3) from b3, the a1 ion (m/z 85.9), and the x1 ion (m/z 143.2). Figure 6C 
shows the MS3 spectrum of the b3 ion from product 10 (m/z 276.3). The major ions in this 
spectrum are the b2 ion (m/z 171.1), and the ion derived from the combined loss of CO and 
ammonia (m/z 229.3). We also observe ions derived from the neutral loss of water from b3 (m/z 
258.2), the a1 ion (m/z 86.1), and the x1 ion (m/z 143.2).  
 ii. b4 fragment ions (m/z 369.2, 369.2, and 375.2 for products 2a, 9, and 10, 
respectively). Figure 2.17 displays the MS3 spectra of the b4 ions from products 2a (m/z 369.2), 
9 (m/z 369.2), and 10 (m/z 375.3). This fragment, shown in the insert in Figure 2.17A, is derived 
from the cyclic sulfenamide through cleavage of the amide bond and the heterocyclic S-N bond. 
It is important to note that b4 is isobaric to y4-H2O in product 2a. However, based on the 
isotopic substitution in b4 from products 9 and 10, m/z 369.2 and m/z 375.2 cannot be assigned 
to y4-H2O. The most intense MS
3 fragment ions derived from the b4 ions of all three peptides are 
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the ions characterized by a loss of 57 Da, i.e., m/z 312.0, 312.1, and 318.1 for products 2a, 9, and 
10, respectively (Figures 2.17A, 2.17B, and 2.17C). The loss of 57 Da may reflect either a direct 
loss of Gly or a sequential loss of CO (28 Da) and CH2=NH (29Da) (a mechanistic scheme for 
the fragmentation pathways will be provided in the Discussion). Other intense fragment ions are 
generated through the loss of Leu and Leu-Gly, i.e. ions with m/z 256.1 and m/z 199.0 for 
product 2a, m/z 256.2 and m/z 199.0 for product 9, and m/z 262.1 and m/z 205.1 for product 10, 
Figure 2.17. MS3 fragmentation of the b4 ion from the MS/MS spectra of (A) product 2a; (B) product 9; (C) product 
10. The 13C and 15N labeled amino acids are indicated in bold font and with *C/N. 
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respectively. Additionally, a neutral loss of CO following the loss of Leu-Gly is observed for 
products 2a, 9, and 10, i.e. ions with m/z 171.1, 171.1, and 176.1, respectively. A direct neutral 
loss CO generated ions with m/z 341.1, m/z 341.3, and m/z 347.2 for products 2a, 9, and 10, 
respectively.   
 iii.VC*V fragment ions (m/z 298.2, 304.2, and 304.2 for products 2a, 9, and 10, 
respectively). More evidence for the cyclic sulfenamide structure is derived from the MS3 spectra 
Figure 2.18. MS3 fragmentation of the VC*V internal fragment ion from the MS/MS spectra of (A) product 2a; 
(B) product 9; (C) product 10. The 13C and 15N labeled amino acids are indicated in bold font and with *C/N, and 




of the internal VC*V fragment of products 2a (m/z 298.2), 9 (m/z 304.2), and 10 (m/z 304.2) 
(Figure 2.18), where C* corresponds to the modified Cys sulfenamide structure. Product 9 and 
10 contained the isotopically labeled Val residues C- and N-terminal of the original Cys residue. 
The main fragment ions of VC*V were derived through the loss of CO, i.e. ions with m/z 270.1, 
m/z 275.1, and m/z 276.1 for products 2a, 9, and 10, respectively. The resulting fragment ions 
were further amenable to loss to ammonia, generating ions with m/z 253.1, m/z 258.1, and m/z 
258.1 for products 2a, 9, and 10, respectively. Fragmentation of VC*V from product 2a leads to 
ions with m/z 171.0 and m/z 199.0, which could each correspond to two different structures 
(displayed in Figure 2.18A). This became apparent through comparison with the fragmentation 
of VC*V from products 9 and 10, which yielded ions with m/z 171.2 and m/z 176.1, and with 
m/z 199.1 and m/z 205.1, respectively. For VC*V from product 9, m/z 199.1 corresponds to the 
loss of CO and 2-methylpropan-1-imine (Figure 2.18B), whereas for VC*V from product 10, 
m/z 199.1 corresponds to the y2 ion (Figure 2.18C). Vice versa, m/z 205.1 corresponds to the 
loss of CO and 2-methylpropan-1-imine from VC*V of product 10, whereas the y2 ion from 
VC*V of product 9 corresponds to m/z 199.1. Furthermore, m/z 171.1 and m/z 176.1 correspond 
to the losses of CO from m/z 199.1 and m/z 205.1 for VC*V from both products 9 and 10.  
 2.3.6 Reaction of Cys-Containing Peptide 1d with Carbon-Centered Radicals 
derived from AAPH. Peptide 1d was dissolved to a concentration of 50 µM in 50 mM sodium 
phosphate at pH 6.0, 7.0, 8.0, 9.0, and 10.0. 400 µL of these solutions were saturated with Ar for 
30 minutes in glass tubes closed with rubber stoppers. Similarly, a solution of 10 mM AAPH was 
saturated with Ar on ice in a glass tube closed with a rubber stopper. Following saturation with 
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Ar, a final concentration of 1 mM AAPH was added to the solution containing peptide 1d and 
the reaction mixture incubated for 1 hour at 37 °C under the Ar. Under these conditions, the 
thermal decomposition of AAPH over 1 hour yielded a total of 4.9x10-6 M carbon-centered 
radicals.50 Scheme 2.3 shows how C-centered radicals are formed by the thermal decomposition 
of AAPH, following release of N2(g) from the molecule. After the reaction was completed, the 
samples were frozen at -20 °C until MS analysis. The reaction products were placed in a 4 °C 
Scheme 2.3. Thermal AAPH decomposition reaction. 
Figure 2.19. LC-MS of the products generated from reaction of peptide 1d with the C-centered radicals derived by thermal 
decomposition of AAPH for 1 hour at 37 °C at different pH values: (A) Control peptide 1d; (B) pH 6.0; (C) pH 7.0; (D) pH 
8.0; (E) pH 9.0; (F) pH 10.0. 
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autosampler and analyzed by HPLC-MS and 
MS/MS using the Q-tof Premier instrument 
(Figure 2.19). Table 2.5 summarizes the 
products generated from the reaction of 
peptide 1d with the C-centered radicals 
derived from AAPH. However, for clarity, 
the MS/MS fragmentation data presented 
below was generated on the LTQ-FT 
instrument from the irradiation of 100 µM 
peptide 1a (Figure 2.13), since the products 
generated during the reaction of peptide 1d 
with AAPH were structurally identical to 
those generated photolytically. This was done 
because the MS/MS fragmentation on the 
LTQ-FT is superior to that of the Q-tof 
Premier instrument. The major reaction products formed at all pH values were the disulfide of 
peptide 1d, product 20a (identical to peptide 1a) and an isobaric species, product 20b (Figure 
2.19) The characterization of product 20b is described below. Interestingly, the broad peak 
containing products 20a and 20b after the exposure of peptide 1d to AAPH is shifted towards 
longer retention times as compared to the peak eluting at ca. 37 minutes in Figure 2.19A, 
representing the disulfide present in small amounts in the control sample (this was repeatedly 
observed in three independent experiments). Product 2a was formed in low yields at pH 8.0-10.0, 
along with two additional disulfide-containing products, products 11 and 12 (Figure 2.19D-F).  
Table 2.5. Products generated after the reaction of peptide 
1d with C-centered radicals derived from AAPH. 
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 i. Product 2a (m/z 656.4). Following a 1 hour reaction with AAPH-derived radicals at pH 
8.0, 9.0, and 10.0 (Figure 2.19D-F), product 2a appeared in yields of approximately 3% relative 
to all products. The MS/MS spectrum for product 2a was identical to the MS/MS spectrum 
generated by photo-irradiation of peptide 1a (Figure 2.2).  
 ii. Products 20a and 20b (m/z 
659.4+2/1317.8+1). At all pH 
values, products 20a and 20b 
were the major reaction products 
detected after the reaction of 
AAPH-derived radicals with 
peptide 1d (Figure 2.19A-F). 
Products 20a and 20b were the 
only products observed at pH 6.0 
and 7.0. The wide peak shape of 
products 20a and 20b at all pH 
values is consistent with the coelution of isobaric reaction products (see below). The MS/MS 
spectra of all the scans over the large peak containing products 20a and 20b were similar (Figure 
2.20), suggesting that products 20a and 20b represent products with a disulfide bond and an 
isobaric cross-link, respectively. Importantly, the MS/MS fragmentation does not distinguish 
between the disulfide and the isobaric cross-link, but does indicate that the Cys residue is 
involved in the cross-link (i.e. the b3, b4, y3, and y4 ions). A suitable cross-link isobaric with the 
disulfide bond would be a dithiohemiacetal (such as shown in structure 20b in Table 2.5), which 
we have detected as a reaction product of various photolytically generated peptide thiyl 
Figure 2.20. MS/MS spectrum of product 20a/20b after the reaction of 
peptide 1d with C-centered radicals derived from AAPH. In the figure ‘u’ 
is the structure highlighted in the box. 
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radicals.29  In order to distinguish structures 20a and 20b, we performed derivatization with 
NEM, as described in section 2.3.7 below. 
 iii. Product 11 (m/z 
658.4+2/1315.8+1). Product 11 
was formed at pH 8.0-10.0 
(Figure 2.19D-F). The m/z 
value suggests that product 11 
is a derivative of products 20a 
and 20b generated by the loss 
2 Da, consistent with one 
double bond in the structure. 
However  the MS/MS data 
presented in Figure 2.21 
cannot provide a clear 
assignment from which 
precursor product 11 is 
derived, although the structure 
presented is derived from 
product 20b. The b3, b4, y3, 
and y4 MS/MS fragmentation 
ions do however confirm the 
location of the double bond to 
Figure 2.21. MS/MS spectrum of product 11 after the reaction of peptide 1d 
with C-centered radicals derived from AAPH. In the figure ‘u’ is the 
structure highlighted in the box. 
 
Figure 2.22. MS/MS spectrum of product 12 after the reaction of peptide 1d 
with C-centered radicals derived from AAPH. In the figure ‘u’ is the structure 














). Product 12 was 
formed at pH 8.0-10.0 (Figure 
2.19D-F). The m/z value is 
consistent with a derivative of 
products 20a and 20b generated by 
the loss of 4 Da, consistent with 
two double bonds in the structure. 
However, like for product 11, the 
MS/MS data do not indicate 
whether the peptide contains a 
disulfide or an isobaric cross-link 
such as a dithiohemiacetal (Figure 
2.22). The MS/MS does localize 
the double bonds to the original 
Cys residues, most likely one 
double bond each to one Cys 
resdue (cf., the b3, b4, y3, and y4 
ions). The double bonds are located between the 
α
C and the 
β
C atoms. 
  2.3.7 Derivatization of AAPH generated Products with NEM. NEM derivatization 
was employed to distinguish between the isobaric products 
Figure 2.23. LC-MS of the products generated from reaction of peptide 1d 
with the C-centered radicals derived by thermal decomposition of AAPH 
for 1 hour at 37 °C at (A) pH 7.0 and  (B) pH 7.0 followed by NEM 
derivatization. 
 
Figure 2.24. LC-MS of the products generated from reaction of peptide 1d 
with the C-centered radicals derived by thermal decomposition of AAPH for 





20a and 20b, and to assign the 
structures of products 11 and 12. 
We chose to derivatize the 
products formed at pH 7.0 and pH 
8.0 and compare the results 
because at pH 7.0, products 11 
and 12 were not generated, but the 
starting material, peptide 1d, 
remained, whereas at pH 8.0, no 
starting material remained, but 
products 11 and 12 were present 
(Figure 2.19). Following the 
incubation of peptide 1d with 
AAPH at pH 7.0 and pH 8.0, 
aliquots were removed and a final 
concentration of 1.8 mM NEM 
was added to the samples. The 
samples were incubated at room 
temperature for one hour, and 
frozen at -20°C until MS analysis. 
The resultant reaction products were then analyzed by HPLC-MS/MS using the Q-tof Premier 
instrument (Figure 2.23 for pH 7.0 and Figure 2.24 for pH 8.0). However, again for clarity, the 
MS/MS fragmentation data presented below was generated on the LTQ-FT instrument from the 
Table 2.6. NEM-derivatized products generated after the reaction of 
peptide 1d with C-centered radicals derived from AAPH. 
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irradiation of 100 µM peptide 1a (Figure 2.13), since the products generated during the AAPH-
induced oxidation of peptide 1d were structurally identical to those generated photolytically. 
Table 2.6 shows the products generated from the AAPH reaction after NEM derivatization of the 
free thiols: peptide 1d+NEM (m/z 785.4), and product 20b+NEM (m/z 721.9+2), 11+NEM (m/z 
783.3), and 12+NEM (m/z 783.4).   
 i. Peptide 1d+NEM (m/z 785.4+1). Before NEM derivatization, peptide 1d elutes at 12.5 
minutes (Figure 2.23A and 2.24A for pH 7.0, and 8.0, respectively), but NEM derivatization 
abolishes this peak. A new peak elutes at 20 minutes with a combined mass of peptide 1d and 
125 Da (m/z 785.4), corresponding to NEM derivatization (Figure 2.23A and 2.24A for pH 7.0, 
and 8.0, respectively). The MS/MS fragmentation of this product was identical to the MS/MS 
fragmentation of Product 3 after NEM derivatization of the photochemical products from peptide 
1a (see above; Figure 2.7). Interestingly, the peak area of the derivatized peptide 1d is larger 
than the peak area of 
the peptide 1d (47% vs. 
29% for pH 7.0 and 
19% vs. 4% for pH 
8.0). The reason behind 
this discrepancy in peak 
area is described below.    




Figure 2.25. MS/MS spectrum of products 20a and 20b after NEM derivatization. 
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transforms the large, wide peak eluting at ca. 40 minutes (Figure 2.23A and Figure 2.24A, for pH 
7.0 and 8.0, respectively) into two distinct peaks eluting at 37 and 43 minutes, respectively 
(Figure 2.23B and Figure 2.24B, for pH 7.0 and 8.0, respectively). The MS/MS of m/z 721.9+2 is 
shown in Figure 2.25. Again, there are co-eluting products in the peak: product 20a with NEM 
derivatization on the N-terminal amine (structure B), and product 20b with NEM derivatization 
on the Cys thiol (structure A). The b2 and b3 ions are only observed for structure B, and the y 
ion fragmentation intensity is much higher for structure B than structure A. However, product 
20b is in equilibrium with its disproportionation products (Scheme 2.4), reforming the thiol, 
structurally identical to peptide 1d, (m/z 660.4) and the thioaldehyde (658.4) (reaction 10). 
Consequently, product 20b has two NEM-derivatization products: m/z 721.9+2 (reaction 11) and 
m/z 785.4 (reaction 12). The second product (m/z 785.4) accounts for the discrepancy between 
the peak areas of peptide 1d before NEM derivatization (m/z 660.4) and after NEM 
derivatization (m/z 785.4) (Figures 2.23 and 2.24). The extra peak area after NEM derivatization 
Scheme 2.4. NEM derivatization products of product 20b. 
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actually corresponds to the disproportionation product of product 20b. To calculate the % yield 
of product 20b, the peak area of m/z 721.9+2 (Figures 2.23B and 2.24B, for pH 7.0 and 8.0, 
respectively) was added to the difference in peak area between m/z 660.4 (Figures 2.23A and 
2.24B, for pH 7.0 and 8.0, respectively) and m/z 785.4 (Figures 2.23B and 2.24B, for pH 7.0 and 
8.0, respectively). Therefore, product 20b accounts for ca. 23% of the products generated after 
the reaction of peptide 1d with the C-centered radicals derived from AAPH at both pH 7.0 and 
pH 8.0. Product 20a accounts for ca. 50% and 64% of the products generated at pH 7.0 and 8.0, 
respectively. Additionally, at 34 minutes, the front of the product 20a peak shows a slight 
shoulder, evidence for another product that could not be assigned because the MS/MS was 
consistent with product 20a. This could point to other isobaric products such as one or more 
peptides containing D-amino acids. Previously, D-amino acids have been observed during the 
photolysis of disulfide-containing model peptides42 and monoclonal antibodies,44 and thiyl 
radical reactions have been proposed to initiate these isomerization reactions. 
 iii. Products 11 and 12+NEM (m/z 783.4+1). At pH 8.0, products 11 and 12 are generated 
from the C-centered radicals derived from AAPH. However, when NEM is added to the solution, 
product 11 disappears and the signal of product 12 is greatly reduced. No products corresponding 
to the NEM addition of the original products were observed, but two new peaks with m/z values 
of 783.4+1 were detected. These products are most likely due to the disproportionation reactions 
of products 11 and 12 via the same mechanism as shown in Scheme 2.4 for product 20b, except 
that the starting materials (products 11 and 12) now contain double bonds on the original Cys 
residues. Therefore so the final products are 2 Da lower in mass than observed for product 20a. 




spectrum is shown in 
Figure 2.26. The b3, b4, y3, 
and y4 localize the NEM 
addition and the loss of 2 
Da from the native peptide 
1d to the Cys residue. 
 2.3.8 1H-NMR of 
Product 2a. Product 2a was 
generated through the 
reaction of 50 µM Peptide 
1d with AAPH.  Peptide 1d 
was dissolved in 50 mM sodium phosphate buffer prepared at pH 9. 10 mM AAPH was dissolved 
in 50 mM sodium phosphate buffer prepared at pH 7.0, and placed on ice. Both solutions were 
placed in glass tubes, capped with rubber stoppers, and saturated with Ar for 30 minutes. Following 
saturation, a final concentration of 1 mM AAPH was added to the peptide solution under Ar and 
the solution incubated for 1 hour at 37 °C. The sample was dried down in a CentriVap concentrator 
and reconstituted in D2O at pD 3.0. The samples were left at room temperature for two days before 
NMR analysis, which was advantageous as the yield of product 2a increased by 10 times compared 
to products 11 and 12, unlike the results shown in Figure 2.19E. (This was confirmed by MS 
following the 1H-NMR acquisition.) 1H-NMR data were collected after 1024 scans and a pulse 
width of 14.25 seconds. 1H-NMR spectra of the unreacted control peptide 1d (1 mM) and of pure 
AAPH (1 mM) were obtained after 32 scans and a pulse width of 14.25 seconds. The region of 




interest for product 2a is between 
5 and 10 ppm where the proton of 
the βC-H bond from the double 
bond at αC-βC of the original Cys 
residue is predicted to show a 
signal around 6.25-6.91 ppm 
(ChemDraw and NMR 
predictor,52 respectively). The 
control peptide 1a and AAPH 
display no signals in this region (the βC-H proton of the Cys residue in 1d is predicted by 
application of ChemDraw to show a signal at 2.9/3.2 ppm). The solution pD was maintained at pD 
3.0 in order to distinguish between sulfenamide 2a and the S-O-bonded product 2b. At pD 3.0, the 
imine in structure 2b is expected to be protonated,56 which results in  a downfield shift of the 
vinylic proton from 7.4 ppm to 8.4 ppm (calculated by NMR predictor).  
 In Figure 2.27, the NMR spectrum between 5.4 ppm and 11.0 ppm is depicted. Peptide 1d 
(bottom panel, light gray) shows no signals in this region. In contrast, AAPH oxidation of 1d leads 
to a signal at 6.27 ppm consistent with the formation of product 2a (top, dark gray), and AAPH 
peaks at 5.8 ppm confirmed by NMR on pure AAPH. This new peak corresponds to the predicted 
peak shifts of the proton attached to the βC-H that is involved in the double bond between the αC-
βC of the Cys residue that is part of the heterocyclic sulfenamide Product 2a.   
 2.3.9 Photo-irradiation of 100 µM Peptide 1a at pH 7.0. In section 2.3.7, the photo-
irradiation of peptides 1a, 1b, and 1c at a concentration of 100 µM at pH 7.0 with λ = 254 nm 
was described with the intent to characterize the sulfenamide structures 2a, 9, and 10. The 
Figure 2.27. 1H NMR of the control peptide 1d (bottom, light gray) and 
the AAPH sample containing product 2a (top, dark gray). 
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photoproducts generated by the irradiation of 100 µM peptide 1a under Ar-saturated conditions 
were analyzed by LC-MS on the Qtof Premier and MS/MS using the LTQ-FT. A representative 
chromatogram was shown after the photo-irradiation of peptide 1a after ten minutes (Figure 
2.13B), however the other interesting photoproducts of peptide 1a were also characterized by 
MS, and will be detailed in this section and Appendix A. It should be noted that the control 
sample in Figure 2.13A contained no trace of photoproducts, however, the LC-MS shows a wide 




peak, not unlike that observed in 
Figure 2.19 during the AAPH 
reaction with Peptide 1d. 
Therefore, the control may have 
contained not only the disulfide 
peptide 1a, but a dithiohemiacetal 
product (20b) as well, but this 
was not tested at that time. The 
tentative structures of the 
resultant photoproducts that have 
not yet been discussed are shown 
in Table 2.7, and the kinetics of peptide 1a degradation were followed for the photoproducts of 
interest in Figure 2.28. There were four major types of photoproducts generated in this 
experiment: disproportionation products (products 3 (m/z 660.41), 5 (m/z 642.41) and 8 (m/z 
642.42)), oxidation products (products 13 (m/z 692.42), 14 (m/z 690.39), and 16 (m/z 706.37)), 
disulfide derivatives  (products 11 (m/z 658.38+2), 12 (m/z 657.37+2), and 15 (m/z 643.41+2)), 
and products generated through H-atom transfer reactions  (products 2a and 2b (m/z 656.39), 4 
(m/z 626.42), 6 (m/z 624.40), 7 (m/z 626.42), 17 (m/z 628.43), 18 (m/z 624.38), and 19a and 
19b (m/z 624.38)). In the following, we will focus predominantly on the characterization of 
products generated via H-atom transfer reactions, specifically products which were not 
previously observed for other, sterically less restricted, model peptides. Hence, we focus 
specifically on the isobaric products with m/z 624.4. The MS/MS spectra of the other products 
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Figure 2.28. Kinetics of formation for products 1a, 2a, 3, 6, 18, and 
19a/19b after UV irradiation at λ = 254 nm of peptide 1a at pH 7.0 (100 




 The time course of photodegradation 
of peptide 1a at pH 7.0 is shown in 
Figure 2.28. The disulfide shows a 
biphasic decomposition with a faster 
rate within the first 5 minutes, 
followed by a slower rate for the 
following 5 minutes. However, it is 
possible that the disulfide is 
completely consumed after 5 minutes, 
and the remaining peak is a 
dithiohemiacetal, similar to product 20b. The major product generated by the irradiation of 100 
µM peptide 1a was the sulfenamide product 2a that is described above (Figure 2.28) However, 
the yield was only 4.5% after 1 minute of irradiation, not 90% as compared to the irradiation of 
100 nM peptide 1a, and only increased to 29% at 5 minutes before starting to degrade. It should 
be mentioned that the yield of the thiol, product 3, was only 4% in this experiment after 10 
minutes of irradiation at pH 7.0, but yields were much larger in experiments at pH 4.0 (data 
shown in Section 2.3.14), so the data was included in Figure 2.28 for comparison. The generation 
of products 6, 18, 19a and 19b after 5 minutes of irradiation was interesting because of their 
isobaric m/z values, m/z624.4, so we attempted to characterize these structures by MS and NMR 
analysis.     
 i. Product 6 (624.38). A trace of product 6 was observed after the irradiation of 100 nM 
peptide 1a, but during the irradiation of 100 µM peptide 1a, product 6 was observed at a 4% 
yield after 10 minutes of irradiation (Figure 2.28). This product elutes at 18 minutes (Figure 
Figure 2.29. MS/MS spectrum of product 6 after UV irradiation at 
λ = 254 nm of peptide 1a at pH 7.0 (100 µM), and tentative 




2.13B), and the m/z value is consistent 
with the conversion of Cys to Dha and 
a loss of 2 Da from the peptide 
(photochemical Cys to Ala conversions 
have been detected earlier with other 
model peptides).40 The MS/MS data 
show an interesting fragmentation 
pattern: no fragment ions could easily 
be assigned to either Dha, or the loss of 
2 Da elsewhere on the peptide (Figure 2.29). However, the m/z values of the b5 and y5 
fragments (compared to the thiol, product 3) clearly indicate the Cys to Ala conversion and the 
loss of 4 Da is confined to the interior residues, and that the N-terminal LG and C-terminal GL 
sequences are unmodified. The signals with the highest intensity are the a5 and b5 ions, but 
below 400 Da, the only signals observed correspond to internal *VAV fragmentation, where the 
*VAV indicates a modification of the original amino acids. One possible rationale for this 
fragmentation pattern would be a cross-link between the C-terminal Val and the carbonyl group 
of the new Dha residue as indicated in the tentative structure given in Figure 2.29. Further NMR 
analysis will be presented below to support the structure presented in Figure 2.29.  
 ii. Product 18 (624.38). Product 18, with a m/z value of 624.38, is isobaric to product 6, 
corresponding to the Cys to Dha transformation with an additional loss of 2 Da. This product 
appears after 5 minutes of irradiation and elutes ca. 5 minutes later than product 6. In the MS/MS 
spectrum the b5 fragment is the ion of highest intensity (Figure 2.30), whereas the remainder of 
the ions show intensities of 10% or less compared to that of the b5 ion. One exception is the ion 
Figure 2.30. MS/MS spectrum of product 18 after UV irradiation 
at λ = 254 nm of peptide 1a at pH 7.0 (100 µM), and tentative 
assignment of a product structure. 
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generated by the loss of water from the molecular ion ([M+H]+1-18; 40% relative intensity). A 
tentative structure of product 18 is shown in Figure 2.30, which contains Dha and a double bond 
between the αC and βC position of the N-terminal Val (dehydrovaline, Dhv). However, we cannot 
detect b3 or y4 ions to confirm this structure. We only detect the b4, y3, and y5 ions localizing 
the loss of a total of 4 Da between the N-terminal Val and Ala residues. This could easily be a 
cross-link, but more experiments must be run to elucidate this structure.   
 iii. Products 19a and 19b (m/z 
624.38). A third set of isobaric products to 
product 6 and 18 elutes at 12 minutes after 
5 minutes of irradiation (Figure 2.13B), 
and again, the m/z value of 624.38 
corresponds to the conversion of Cys to 
Dha and Val to Dhv. In the MS/MS 
spectrum (Figure 2.31) of products 19a 
and 19b we detect a b4 ion corresponding 
to Dha and N-terminal Dhv residues 
(product 19a), and b4 and y4 ions corresponding to Dha and C-terminal Dhv (notated b4’ and 
y4’) (product 19b). The structures presented in Figure 2.31 show the double bond on the Dhv 
residues between the βC and γC position, and not the αC and βC position; however, like in product 
7, we cannot make this distinction purely from this MS/MS analysis, but BME derivatization 
results (shown below) support such a structure. 
 2.3.10 Derivatization of Products 6, 18, 19a, and 19b with β-mercaptoethanol 
(BME). To determine whether the double bonds in the isobaric products 6, 18, 19a and 19b are 
Figure 2.31. MS/MS spectrum of product 19a/19b after UV 
irradiation at λ = 254 nm of peptide 1a at pH 7.0 (100 µM), 




located between the βC and γC or the αC 
and βC position, the photoproducts 
generated from the 100 µM peptide 1a 
were derivatized with a final concentration 
of 10 mM BME. The distinction of the 
double bond location was possible because 
BME only adds to α,β-unsaturated 
carbonyls48,49 (i.e., only if the double bond 
is located between the αC-βC bond). The pH 
was adjusted to pH 7.8 with 50 mM ammonium bicarbonate buffer, and the reaction proceeded at 
room temperature for two hours. MS analysis was performed on the LTQ-FT instrument. Since a 
thorough analysis of the BME-derivatized photoproducts was described in Section 2.3.3, only 
BME addition to products 6, 18, 19a, and 19b were searched for in the new mass spectrometry. 
Interestingly, BME added only to product 19a, resulting in product 19a+BME with an m/z value 
of 702.39 (Figure 2.32). No products resulting from the addition of two equivalents of BME 
were observed, as was expected with product 18. The MS/MS spectrum of the BME-derivatized 
product, 19a+BME, is not entirely conclusive. The b4 and y5 ions localize the BME addition to 
either the Ala (as drawn) or the N-terminal Dhv, if the double bond were located between the αC 
and βC position of Val (as is the case for product 18). Since the reaction mixture contained the 
four isobaric products, it is unclear which product(s) reacted with BME, but it is fair to assume 
that based on these results, the double bond in at least some of the isobaric products with m/z 
624.4 is located between the βC and γC position. Another reason for the lack of BME addition 
could be related to incorrect structural assignment of the products. Cross-links in the structures, 
Figure 2.32. MS/MS spectrum of product 19a after BME 





and not Dha and Dhv, could explain the lack of BME addition. However, due to the lack of 
supporting data, other structures are just speculative and therefore, not presented.  
 2.3.11 1H-1H TOCSY NMR (TOtal Correlated SpectroscopY) of irradiated peptide 
1a. To identify the structures of the isobaric products, specifically product 6, peptide 1a was 
dissolved in water at pH 7.0 to a concentration of 100 µM, saturated with Ar, and irradiated at λ 
= 254 nm for 10 minutes. The resultant photoproducts were then purified by HPLC on a reverse 
phase C18 column, but sufficient yields of the purified products could not be collected for NMR 
analysis. To this end, we analyzed the entire photo-irradiated sample before (control) after 
irradiation at λ = 254 nm for 10 minutes. The samples were dried down in a CentriVap 
concentrator and diluted with D2O prior to NMR analysis. 
1H-1H TOCSY NMR spectra were 
recorded on a Bruker Avance 800 MHz NMR instrument, equipped with a TCI cryoprobe, and 
chemical shifts were predicted in ChemBioDraw Ultra 13.0 (Perkin Elmer, Waltham, MA). 
NMR data were analyzed using MestReNova version 9.0 (Mestrelab Research, Santiago de 
Compostela, Spain). 1H-1H TOCSY experiments help elucidate coupling networks for protons 
directly coupled together (i.e. mutual J-coupling) and protons connected by a chain of couplings, 
such as amino acids (i.e. same spin system, but not mutual J-coupling. Through these 
interactions, the same amino acid in different locations of a peptide (such as the Leu, Gly, and 
Val residues) can be distinguished, since each amino acid has a separate spin system in the 
peptides. The spectra show diagonal and cross-peaks, where the cross-peaks indicate coupling 
between protons.  
 Figure 2.33 shows the 1H-1H TOCSY NMR spectraof the control (purple) overlayed on 
the photo-irradiated samples (black), and the corresponding amino acids characterized by the 
crosspeaks. The crosspeaks in the spectra overlayed nicely, except that the Cys peaks (3.0, 2.9 
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ppm) were missing in the 
irradiated samples. This was 
expected as the mass 
spectrometry analysis revealed 
that the Cys residues were 
modified in many of the 
photoproducts, e.g. to Ala and 
Dha. Several peaks shifted in the 
regions around 0.8 and 1 ppm, 
and 1.2 and 4 ppm. Another 
noticeable difference was the absence of a Val peak (2.1, 4.0 ppm), notated ‘Val 1’ in the spectra 
since there are two Val residues in peptide 1a, an indication that one of the Val residues was 
modified after irradiation. Nevertheless, a new peak could not be assigned to a modified Val 
residue, so the structure for product 6 is still tentative.  
 2.2.12 1H-13C HSQC NMR (Heteronuclear Single Quantum Coherence) of 
irradiated peptide 1a. We continued to probe the structure of product 6 by NMR spectroscopy 
of the stable isotope-labeled peptides 1b and 1c, since the 1H-1H TOCSY NMR analysis of the 
photoproducts from non-isotopically labeled peptide 1a was encouraging, yet non-conclusive. 
Peptides 1b and 1c were dissolved at pH 7.0 to a concentration of 100 µM, Ar-saturated, and 
irradiated at λ = 254 nm for 10 minutes. The resultant photoproducts were then purified by 
HPLC on a reverse phase C18 column, but again, sufficient yields of purified material could not 
be collected for NMR analysis. As for the other NMR experiments, we analyzed the entire 100 
µM sample before (control) and after photo-irradiation at λ = 254 nm for 10 minutes. The 
Figure 2.33. 1H-1H TOCSY NMR spectrum of the control non-
irradiated (purple) and irradiated (black) peptide 1a samples after 




samples were dried down in the CentriVap concentrator and diluted with D2O prior to NMR 
analysis. 1H-13C HSQC NMR spectra were recorded on a Bruker Avance 800 MHz NMR 
instrument, equipped with a TCI cryoprobe and the chemical shifts were predicted in 
ChemBioDraw Ultra 13.0 (Perkin Elmer, Waltham, MA). NMR data were analyzed using 
MestReNova version 9.0 (Mestrelab Research, Santiago de Compostela, Spain). 1H-13C HSQC 
NMR experiments help elucidate coupling networks for protons directly coupled to 13C. Since 
only the Val residues were 13C-labeled, only the Val residues will be observed by 1H-13C HSQC 
NMR analysis, rendering the analysis much simpler than for the whole peptide. The chemical 
shifts of modified Val with double bonds were markedly different, as predicted by ChemDraw. 
The 13C chemical shift predictions for the αC, βC, and γC positions of the unmodified Val 
residues were 61.7, 31.1, and 18.5 ppm, respectively. The 13C chemical shift predictions for the 
αC, βC, and γC positions of the Val with a double bond between the αC and the βC position were 
149.5, 120.3, and 21.6 ppm, respectively. The 13C chemical shift predictions for the αC, βC, and 
γC positions of the Val with a double bond between the βC and the γC position were 68.8, 136.6, 
19.8 and 118.6 ppm, respectively. If the γC atom of a Val residue is cross-linked to the Ala 
carbonyl group, the 13C chemical shift predictions  for the αC, βC, and γC positions of the 
modified Val residue were 56.4, 34.1, 11.4 and  69.1ppm, respectively. When the control peptide 
1b was analyzed by NMR, the chemical shifts of αC, βC, and γC carbons recorded were very 
similar to the predicted values (59.3, 30.0, and 18.0 ppm, respectively) (data not shown because 
the peaks were also observed in the irradiated sample, see below).  
Figure 2.34 shows the 1H-13C HSQC NMR spectrum of a solution of peptide 1b after 
photolysis. The peaks of the control sample (59.42, 30.20, and 17.88 ppm for the αC, βC, and γC 
position, respectively) are still observed indicating that only part of peptide 1d was converted to 
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products. However, two additional 
13C signals were observed at 66.66 
and 19.41 ppm. Clearly, these 
additional peaks do not correspond to 
a double bond on the Val residue 
located either between the αC and βC 
or the βC and γC position. However, 
the peaks are fairly consistent with 
the proposed cross-link between the 
Val γC and the Ala carbonyl group proposed for product 6.  The proposed structure of product 6 
is displayed Figure 2.34 together with the predicted chemical shifts for the individual 13C atoms. 
Here the βC signal remains largely unchanged, but new signals appear for the αC-H and γC-H 
positions. Although the peak predictions do not completely agree with our experimental data, 
this modified Val structure is our best estimate as to the structure of product 6. NMR 
experiments with the photo-irradiated peptide 1c were not successful (too low yields of 
individual products). 
 2.3.13 Ozonolysis of Photoproducts Generated during Photo-irradiation of 100 µM 
Peptide 1a at pH 7.0. In an attempt to further characterize the location of the double bonds in 
products 6, 18, 19a, and 19b, the photoproducts generated during the 10 minute photo-irradiation 
of peptide 1a at λ = 254 nm at pH 7.0 were treated with ozone (O3) following irradiation. The O3 
was generated with an Ozotech ozonolysis apparatus and bubbled directly into the control and 
irradiated samples for 30 seconds at room temperature (in glass tubes) or bubbled into water for 
2 minutes, and then the O3-containing water was added to the samples. Reduction of the resultant 
Figure 2.34. 1H-12C HSQC NMR spectrum of peptide 1b after 




Criegee intermediate (Scheme 2.5, reaction 15) was accomplished with sodium borohydride. The 
samples were then frozen at -20 °C until MS analysis. Scheme 2.5 shows how ozone reacts with 
double bonds, and how it is reduced with sodium borohydride to yield hyoxyl adducts.  
Interestingly, no hydroxyl products were observed in the photo-irradiated samples, 
although we hypothesized that ozonolysis of products 6, 18, 19a, and 19b may generate such 
products. There was also no trace of backbone fragmentation products, commonly observed 
when hydroxyl groups are present on the αC of a peptide.57 We know from our BME experiments 
that there is at least a trace of Dha in one of the products. The absence of expected ozonolysis 
products could again indicate our initial structural assignments of products 6, 18, 19a, and 19b 
were incorrect, or the bulkiness of the Val residues hinders the 1, 3-cycloaddition of O3, and 
therefore the ozonolysis products cannot be formed. 
 2.3.14 Photo-irradiation of 100 µM Peptide 1a at pH 4.0. Peptide 1a was dissolved in 
water at pH 4.0 to a concentration of 100 µM. Solutions were saturated with Ar and irradiated at 
λ = 254 nm. The photoproducts generated were analyzed by LC-MS on the Qtof Premier and 
MS/MS using the LTQ-FT instrument. A representative chromatogram for control and photo-
irradiated peptide 1a at pH 4.0 is shown in Figure 2.35, and the kinetics of photoproduct 
formation are shown in Figure 2.36. It should be noted that the control sample in Figure 2.35A 
shows no traces of photoproducts; however, the chromatogram shows a wide peak for peptide 1a. 
Therefore, the control may have contained not only the disulfide peptide 1a, but additionally a 




dithiohemiacetal product (20b), 
but this was not tested at the 
time. In addition to the 
photoproducts discussed in the 
previous sections, the tentative 
structures of the resultant 
photoproducts, generated at pH 
4.0, that have not yet been 
discussed are shown in Table 
2.8. There were four major 
types of 
photoproducts 
generated in this 
experiment: 
disproportionation 
products (product 3 
(m/z 660.41), 5 (m/z 
642.41) and 8 (m/z 
642.42)), disulfide 
derivatives  (product 
11 (m/z 658.38+2), 12 (m/z 657.37+2), 15 (m/z 43.41+2), 21 (m/z 642.41+2), and 22 (m/z 
641.42+2)), and products generated through H-atom transfer reactions  (m/z products 2a and 2b 
(m/z 656.39), 6 (m/z 624.40), 19a and 19b (m/z 624.38)).  
Figure 2.35. LC-MS analysis of the photoproducts generated by UV-
irradiation at λ = 254 nm of peptide 1a (100 µM) in Ar-saturated H2O at pH 
4.0 in the (A) control and (B) the sample after 10 minutes of irradiation. 





The time course of 
photodegradation of peptide 1a at 
pH 4.0 is shown in Figure 2.36. Like 
in the experiments at pH 7.0, the 
disulfide decomposition shows 
biphasic kinetics. The major product 
generated by the irradiation of 100 
µM peptide 1a at pH 4.0 was 
product 3. The yield of product 3 
was much higher at pH 4.0 as 
compared to pH 7.0, reaching 45% 
after 10 minutes of irradiation. Two 
new disulfide derivative products were observed during the irradiation, thioether products 21 and 
22, with m/z 642.41+2 and m/z 641.38+2, respectively. Another interesting observation during the 
irradiation at this low pH was the absence of the isobaric product 18, whereas products 6, 19a 
and 19b were formed in similar yields. The MS/MS data between the irradiation at pH 4.0 was 
consistent with the MS/MS data presented at pH 7.0. 
2.4 Discussion  
 The photolysis of low concentrations of peptide 1a, (LGVCVGL)2, at λ = 254 nm under 
Ar predominantly generates the isothiazole-3(2H)-one 2a. This product contains an S-N bond 
between the sulfur of the original Cys residue and the nitrogen of its C-terminal peptide bond. 
During just one minute of irradiation, peptide 1a was converted ca. 90% into product 2a. This 
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Figure 2.36. Kinetics of formation for products 1a, 2a, 3, 6 and 
19a/19b after UV irradiation at λ = 254 nm of Peptide 1a at pH 4.0 




beta-mercaptoethanol (BME), and 1H-NMR. The analogous product was also formed in the 
isotopically-labeled peptides 1b and 1c, i.e., products 9 and 10, respectively. In addition, product 
2a is generated via AAPH-dependent oxidation of peptide 1d at pH 8.0-10.0, although in much 
lower yield.  
 The chemical derivatization reactions of NEM and BME with product 2a were imperative 
in characterizing the S-N bond. NEM reacts with free thiols and amines,47 whereas BME reacts 
with α, β-unsaturated carbonyl groups48,49 and cleaves the S-N bond.58 The MS/MS 
fragmentation patterns between underivatized product 2a (Figure 2.2), and N-terminal NEM-
derivatized product 2a (Figure 2.6) were very similar in the sense that in both MS/MS spectra the 
loss of water from the parent ion was the most intense fragment ion and the intensity of all the b 
and y ions were ca. 15% normalized to the parent ion which lost water, indicating that NEM did 
not react with the modified Cys residue. Furthermore, C*V, VC*V, and C*VG internal 
fragments (where C* represents the modified Cys residue) also fell in this range of relative 
abundance, suggesting that the original Cys and the C-terminal Val residue  were cross-linked in 
another way than solely the amide bond. This is suggested by the relatively high intensity of 
these internal fragment ions compared to the standard b and y ions. When product 2a was 
derivatized with BME, two products were formed: a mono-derivatization and di-derivatization 
product. The mono-derivatized product 2a+BME contained a single BME adduct on the original 
Cys residue (Figure 2.10). During fragmentation, no longer was the b4 ion of low intensity 
(15%), but now it was of ca. 50% signal intensity relative to the hightest intensity ion, the y6 ion. 
This large change in b4 ion intensity is most likely due to the cleavage of the S-N bond, forming 
a new disulfide between the isothiazole-3(2H)-one sulfur and the BME thiol. This should allow 
for an easier formation of the b4 ion since energy does not have to be expended for cleavage of 
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the S-N bond in the gas-phase. Similarly, with sulfenamide pro-drugs, the mechanism of drug 
release involves cleaving the S-N bond through hydrolysis or the formation of a disulfide by 
addition of a nucleophilic thiol.59,58 The MS/MS analysis of the double BME derivatization 
product 2a+2BME (Figure 2.11), reveals that two BME molecules are attached to the original 
Cys residue, consistent with the additional derivatization of the double bond between the αC and 
βC positions of the modified Cys residue. 
 1H-NMR analysis provided complementary support for the formation of the isothiazole-
3(2H)-one structure in product 2a. The experimental chemical shift, 6.27 ppm, matched the 
predicted chemical shift of the  βC-H group involved in the double bond between the αC and the 
βC position of the original Cys residue in product 2a, and not the predicted chemical shift for 
product 2b. Unfortunately, since this NMR sample did not contain pure product 2a, we cannot 
say that this peak was only due to product 2a, just an indication since small amounts of product 
11 and 12 were also present. Additionally, NMR predictors do not generally take into account 
the conformation of the peptide, which plays an important role in distinguishing product 2a from 
product 2b. Ideally, pure products 2a, 9, and 10 should be collected for 1H-NMR and 13C-NMR, 
and a standard peptide with a known isothiazole-3(2H)-one structure should be synthesized and 
analyzed to be entirely confident in our structural assignment of product 2a.  
 Sulfenamide formation has been reported in oxidative environments, through reduction of 
sulfinic acid, or transformation of a thiol into a reactive sulfur halide followed by reaction with an 
amine.60 Interestingly, a cyclic sulfenamide was formed in the peptide PFKCG under oxidative 
conditions only if a nearby Lys was available for cross-linking, and not if the Lys was replaced by 
Val.53 After oxidation of PFLCG, only intermolecular cross-links were observed. Since the peptide 
we used to generate the intramolecular sulfenamide (isothiazole-3(2H)-one) did contain Val 
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residues, the sulfenamide products generated by these two different methods (oxidation and 
photolysis) are likely formed by very different mechanisms. The formation of the isothiazole-
3(2H)-one 2a is likely the result of steric constraints, which disfavor intermolecular reactions of 
thiyl radicals, since previous studies with model peptides (LGACAGL)2 and (GGCGGL)2 showed 
no significant yields of any heterocyclic product. The only differences between these model 
peptides are the amino acid residues in the i+1 and i-1 position to the Cys disulfide. The bulky 
lateral isopropyl groups of Val provide much greater steric hindrance in peptides compared to the 
Ala methyl group and the proton on Gly. Photolysis of a model peptide with Leu at the i+1 and i-
1 positions will be important to test the steric constraints when a tert-butyl group is near the 
disulfide bond. 
 In scheme 2.6, we propose a mechanism for the formation of the isothiazole-3(2H)-one 
products 2a, 9 and 10. During the irradiation, the disulfide bonds in peptides 1a, 1b and 1c are 
homolytically cleaved, each yielding a pair of thiyl radicals (reaction 17). Within the solvent 
Scheme 2.6. Proposed reaction scheme for the formation of products 2a, 9, and 10.  
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cage, a thiyl radical can undergo intramolecular H-atom transfer with the αC-H bond (reaction 
18). Next, electron transfer between the newly generated C-centered radical and a thiyl radical 
create a αC carbocation and a thiolate (reaction 19). Subsequently, the thiolate can abstract the 
βC-H proton from the carbocation to neutralize the charges, yielding a thiol and vinyl thiol 
(reaction 20). From here, we hypothesize that at pH 7.0 or above (where our reactions take 
place), the thiol is in equilibration with the thiolate anion (reaction 21). Light-induced electron 
ejection from a vinyl thiolate under continuous photo-irradiation with UV light forms a vinyl 
thiyl radical (reaction 22).61 Subsequently, the amide nitrogen reacts with this S-centered radical 
to create a 2 center, 3 electron bond62,63 (reaction 23), which is then oxidized to form the S-N 
cross-link in product 2a, 9, and 10 (reaction 24). The same reaction scheme, presented in Scheme 
2.6, is consistent with the formation of product 2a during the reaction of peptide 1d with AAPH, 
except that the vinyl thiyl radical will be generated through reaction of vinyl thiol with AAPH-
derived carbon-centered radicals.  
 Very unique to product 2a is the double bond between the αC and the βC position. This is 
indicative of a radical mechanism including thiyl H-atom and electron transfer from the αC-H. In 
Scheme 2.6, we presented a vinyl Cys as the intermediate step before the sulfenamide formation, 
but we hardly see a trace of the vinyl thiol product during irradiation. We propose that this is a 
very short-lived intermediate that is quickly transformed into the isothiazole-3(2H)-one product 
2a. Product 2a is relatively stable, surviving irradiation for up to ten minutes under harsh 
conditions that completely cleave the original disulfide bond within a minute.  
 Peptide 1a and the 13C and 15N isotopically-labeled peptides, 1b and 1c, were used to 
support the structure of the isothiazole-3(2H)-one by MS3 characterization (Figures 2.16-2.18).  
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The different isotopic distributions between the peptides has allowed us to assign fragmentation 
pathways, which will be discussed below (Schemes 2.7-2.9). We acknowledge that the structures 
assigned to the fragment ions presented in Figures 2.16-2.18 and Schemes 2.7-2.9 are tentative.  
 i. MS3 fragmentation mechanisms for the b3 ions (m/z 270.2, 270.2, and 276.2 for 
products 2a, 9, and 10, respectively). The b3 fragment ions of products 2a, 9, and 10 did not 
include the sulfenamide S-N bond, only the LGV sequence on the N-terminal side of the peptide 
(Figure 2.16). The m/z values of products 2a and 9 were identical, whereas product 10 contained 
the isotopically-labeled N-terminal Val group, so some fragment ions were 6 Da higher than 
those of the other two products. Scheme 2.7 shows a proposed mechanism for the generation and 
reactions of fragment ions of b3. There seems to be three initial pathways stemming from the 
fragmentation of the initial b3 ion: peptide bond cleavage (reaction 25), neutral loss (reaction 
28), and internal cyclization (reaction 36). The ion with the highest intensity in products 2a and 
Scheme 2.7. Proposed reaction scheme for the MS3 fragmentation of the b3 ion of product 2a (m/z 270.2), 9 (m/z 270.2), 
and 10 (m/z 276.2).  
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10 is the b2 ion, generated by cleavage of the Val residue, m/z 171.1 (reaction 25). This ion was 
present in the MS/MS of product 9, but not as the ion with the highest intensity. Although this 
could indicate that product 9 has a different structure than the other two products, the MS/MS of 
this product exactly matched those of products 2a and 10, and the MS3 of the b4 ion and of the 
VC*V internal fragment ion also matched closely. Therefore, the difference was not examined 
further. Following the b2 ion fragmentation, loss of the carbonyl (reaction 26) and glycyl-like 
(reaction 27) groups were observed, generating ions with m/z 143.1 and m/z 86.1, respectively. 
The second major pathway began with the loss of the carbonyl group (reaction 28), followed by 
internal cyclization (reaction 29) and loss of the ammonia group (reactions 30-34). The third 
pathway started with internal cyclization (reaction 35), and along the way, loss of water (reaction 
38) and a carbonyl group (reaction 41) were observed.  
 ii. MS3 fragmentation mechanisms for the b4 ions (m/z 369.2, 369.2, and 375.2 for 
products 2a, 9, and 10, respectively). Scheme 2.8 shows the proposed mechanisms of ion 
formation from the fragmentation of the b4 ion. This b4 fragmentation cleaves the sulfenamide 
bond as well as the peptide bond between the Cys and C-terminal Val residue. The b4 ion is 
larger in size than the b3 ion, so more of the major fragments include the loss of amino acids, not 
neutral fragments. Initially, cyclization between the N-terminal amine and the C-terminal 
carbonyl cation forms a large 12-membered ring (reaction 42). Then, the mobile proton moves to 
a different amide nitrogen (reaction 43), leading to the favorable amide bond cleavage (reaction 
44), carbonyl loss (m/z 341.14, 341.2, and 347.2 for product 2a, 9, and 10 respectively) (reaction 
45), and finally methanimine loss (m/z 312.2, 312.2, and 318.2 for product 2a, 9, and 10, 
respectively) (reaction 46). When the mobile proton moves to a different amide nitrogen after the 
first cyclization (reaction 47), ring opening between the Leu and Gly (reaction 48) allows Leu 
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fragmentation (reaction 49), followed by Gly fragmentation in reaction 51. From here, the 
mobile proton can move to protonate the Cys amide nitrogen (reaction 52) and open the cycle 
(reaction 53), creating the carbonyl cation on the Val group. This is then quickly cleaved, 
creating the fragment ions with m/z 171.1, 171.1, and 176.1 for product 2a, 9, and 10, 
respectively (reaction 54). It should be noted that for product 10, the carbonyl was 13C-labeled, 
so a loss of 29 Da was observed, not of 28 Da. Interestingly, a fragment ion with m/z 171.1 was 
previously seen during b3 ion fragmentation, but now instead of being a major peak, it is minor. 
There is also no hint of a carbonyl loss from the ion with m/z 171.1 here in the b4 fragmentation 
that we, instead, observed in the b3 ion fragmentation (i.e. m/z 143.1). This suggests the 
structure from the ion with m/z 171.1 in the b4 fragmentation is very different from the b3 
fragment ion with m/z 171.1 and does not contain a C-terminal carbonyl group.  
Scheme 2.8. Proposed reaction scheme for the MS3 fragmentation of the b4 ion of product 2a (m/z 369.2), 9 (m/z 
369.2), and 10 (m/z 375.2).  
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 iii. MS3 fragmentation mechanisms for the VC*V internal fragment ions (m/z 298.2, 
304.2, and 304.2 for products 2a, 9, and 10, respectively). The pathway of formation to the MS3 
ions from the internal fragment ion VC*V is shown in Scheme 2.9. This fragment ion still 
contains the intact isothiazole-3(2H)-one, and both product 9 and 10 contain isotopically labeled 
Val residues, albeit on the C-and N-terminal Val, respectively. The largest fragment ion observed 
in Figure 2.18 corresponds to the loss of the C-terminal carbonyl group (reaction 55). Next along 
this pathway, the heterocycle is opened and the mobile proton moves to the Cys amide nitrogen 
(reaction 56). Here, the mobile proton can move to the N-terminus and ammonia is cleaved 
(reactions 62 and 63), or it can move to the Val amide nitrogen (reaction 57), whereby internal 
cyclization from the N-terminal amine to the Cys carbonyl group cleaves off the C-terminal Val 
group (reaction 58). The remaining product 10 fragment ion contains the N-terminal isotopically 
labeled Val residue (m/z 205.1), whereas product 2a and 9 do not contain an isotopically N-
terminal Val residue (m/z 199.1). Movement of the mobile proton to the Cys amide (reaction 59) 
and ring opening (reaction 60) allows the Val carbonyl group to be cleaved (m/z 171.1, 171.1, 
and 176.1 for products 2a, 9, and 10, respectively (reaction 61). Interestingly, another 
Scheme 2.9. Proposed reaction scheme for the MS3 fragmentation of the b4 ion of product 2a (m/z 298.1), 9 (m/z 304.1), 
and 10 (m/z 304.1).  
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fragmentation pathway yields ions with the exact same m/z values, but the isotopically labeled 
C-terminal Val residue is retained instead of the N-terminal Val (reactions 64 and 65). The y2 
fragment ion generates ions with m/z 199.1 in products 2a and 10, and m/z 205.1 in product 9 
(reaction 64). The carbonyl group is easily cleaved from the y2 fragment yielding ions with m/z 
171.1, 176.1, and 171.1 for products 2a, 9, and 10, respectively (reaction 65). Interestingly, this 
y2 fragmentation pathway does not seem to be as favorable as the former pathway because the 
intensities of these ions seem to be lower in product 9 and 10. Since product 2a does not contain 
any isotopic labels, the m/z values for the different fragment ions are the same.  It should also be 
noted that product 10 yields an ion with m/z 275.1, corresponding to a carbonyl loss from 
product 9. 
 Although the major objective in this chapter was the elucidation of the isothiazole-3(2H)-
one structure, we were also interested in the four minor isobaric photoproducts generated after 
the photolysis of peptide 1a at 100 μM concentration (products 6, 18, 19a, and 19b). Although 
they were formed in low yields, they were most likely products of H-atom transfer reactions. 
These products all were consistent with the transformation of Cys to Dha and an additional loss 
of 2 Da from the product peptide. Their MS/MS spectra were all very different, and likely 
characteristic for their structures, but presently we could not elucidate their structures in all detail 
except that for product 6, although BME addition and NMR spectra were recorded. These 
photoproducts need to be collected individually so that specific derivatization chemistry can be 
performed separately to allow for more accurate analysis.  
 The formation of the isothiazole-3(2H)-one products from peptide 1a was proposed to 
occur intramolecularly, however, intermolecular dithiohemiacetal products were also observed 
during the photolysis of peptide 1a and the reaction of peptide 1d with C-centered radicals 
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derived from AAPH. In fact, the dithiohemiacetal product 20b was a major product, accounting 
for ca. 23% of the reaction products after the AAPH reaction at pH 7.0 and pH 8.0, whereas the 
disulfide, product 20a, accounted for 50 and 64%, respectively. The dithiohemiacetal products 
have been reported previously as photolysis products from several peptides and proteins,29,30,64 
but not after the reaction of thiols with AAPH. 
2.5 Conclusion 
 This report provides the first evidence for a heterocyclic peptide product generated via 
light stress. The potential for light to form an isothiazole-3(2H)-one structure with such 
efficiency is of interest to the pharmaceutical industry as disulfide bonds are present in many 
protein therapeutics. The peptide studied, (LGVCVGL)2, was unique due to the Val residues at 
the i+1 and i-1 positions relative to the reactive disulfide bond, sterically straining this peptide. 
Previous peptides containing Ala or Gly next to the disulfide bond showed no trace of such 
structures after photolysis, highlighting the importance of conformation for protein and peptide 
stability. This product is of further interest to protein stability because dehydroamino acids and 
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Figure A.1. MS/MS spectrum of product 7 after UV irradiation at λ = 254 nm of Peptide 
1a at pH 7.0 (100 µM) in an Ar-saturated H2O. 
 
Figure A.1. LC-MS analysis of the photoproducts generated by UV-irradi ion at λ = 254 nm of Peptide 1a (100 
nM) in Ar-saturated H2O, pH 7.0: (A) no irradiation (control); (B) 30 seconds of irradiation; (C) 1 minute of 
irradiation; (D) 2 minutes of irradiation; (E) 5 minutes of irradiation; (F) 10 minutes of irradiation. 








Figure A.3. MS/MS spectrum of product 13 after UV irradiation at λ = 254 nm of Peptide 
1a at pH 7.0 (100 µM) in an Ar-saturated H2O. 
 
Figure A.2. MS/MS spectrum of product 7 after UV irradiation at λ = 254 nm of Peptide 

































Figure A.4. MS/MS spectrum of product 14 after UV irradiation at λ = 254 nm of Peptide 
1a at pH 7.0 (100 µM) in an Ar-saturated H2O. 
 
Figure A.5. MS/MS spectrum of product 15 after UV irradiation at λ = 254 nm of Peptide 

































Figure A.6. MS/MS spectrum of product 16 after UV irradiation at λ = 254 nm of Peptide 
1a at pH 7.0 (100 µM) in an Ar-saturated H2O. 
 
Figure A.7. MS/MS spectrum of product 17 after UV irradiation at λ = 254 nm of Peptide 










Figure A.8. MS/MS spectrum of product 21 after UV irradiation at λ = 254 nm of Peptide 
1a at pH 4.0 (100 µM) in an Ar-saturated H2O. 
 
Figure A.9. MS/MS spectrum of product 22 after UV irradiation at λ = 254 nm of Peptide 




























Due to its indole side chain, tryptophan (Trp) is the strongest UV-absorbing amino acid 
and a major target for photochemical degradation.
2
 For example, Trp can be oxidized to N-
formyl kynurenine (NFK) and kynurenine and sensitize the reduction of peptide and/or disulfide 
bonds, forming thiyl radicals and thiolate.
3,4
 The latter process requires photo-induced electron- 
or H-atom transfer between Trp and the disulfide bond. Modification of Trp residues in proteins 
has resulted in conformational changes and loss of biologic activity, and presents a major 
concern for the production and formulation of biopharmaceuticals.
5,6,7 
Moreover, kynurenines are 








C side chain 
fragmentation reactions of Trp-derived radical cations.
9,10,11 
A side chain fragmentation was also 
reported as key to the enzyme-catalyzed conversion of Trp to 3-methyl-2-indolic acid, but the 
mechanism has not been characterized in detail.
12 







C side chain cleavage of Trp may also be expected during 
photodegradation of protein pharmaceuticals. Here, we show that the exposure of IgG1 to light 
indeed results in the fragmentation of Trp, resulting in the formation of Gly and/or Gly 
hydroperoxide. Additionally, photoirradiation of a synthetic model peptide containing Trp and a 
disulfide bond shows the Trp to Gly hydroperoxide modification. As a consequence, light 
exposure not only modifies the original amino acid (Trp) but also leads to the generation of a 
reactive hydroperoxide. Amino acid hydroperoxides have been shown to exhibit higher reactivity 
towards some oxidation targets as compared to hydrogen peroxide, implying that products such 
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3.2 Experimental methods 
 3.2.1 Materials. Ammonium bicarbonate (NH4HCO3), N-ethylmaleimide (NEM), 
dimethyl sulfoxide, sodium borohydride, L-glutathione oxidized (GSSG), β-mercaptoethanol 
(BME), thioanisole, 1,2 ethanedithiole (EDT), and anisole were supplied by Sigma-Aldrich (St. 
Louis, MO) at the highest commercially available purity. Methanol, ethanol, dichloromethane, 
acetonitrile, and trifluoroacetic acid were supplied by Fisher Scientific (Pittsburg, PA). 
Sequencing grade Trypsin and Glu-C were purchased from Promega (Madison, WI). Deuterium 
oxide (D2O, 99.9%) was purchased from Cambridge Isotope Laboratories (Andover, MA, USA). 
Fmoc-L-Gly, Fmoc-L-Cys-trt, and Fmoc-L-Leu, and Fmoc-L-Trp-Boc were supplied by 
Novabiochem (Darmstadt, Germany), and Fmoc-L-Leu-PEG-PS was supplied by Applied 
Biosystems (Foster City, CA). O-(7-Azabenzotriazole-1-yl)-N, N,N’N’-tetramethyluronium 
hexafluorophosphate (HATU) was supplied by GenScript Corporation (Piscataway, NJ). The 
peptide GGCGGL-GGCWGL was supplied by American Peptide Company (Sunnyvale, CA), 
and the IgG1 was provided by Amgen Inc.  
 3.2.2 Peptide Synthesis. The model peptide (LGGCWGL)2 was synthesized from its 
linear Cys-containing  peptide LGGCWGL using solid phase Fmoc-chemistry on a Pioneer
TM
 
Peptide Synthesis System. Following the synthesis, the crude material was washed with 
methanol and dichloromethane. The thiol was deprotected and the peptide was cleaved from the 
resin using reagent R (TFA, thioanisole, EDT, and anisole at a ratio of 90%:5%:3%:2% (v:v:v)) 
as described in detail elsewhere.
15
 LGGCWGL was purified from the crude mixture by HPLC 
using a YMC-Pack ODS-A semipreparative C18 column with dimensions of 250 x 20 mm ID 
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containing 5 µm particles (YMC America, Inc. Allentown, PA), with a 5 ml min
-1
 flow rate. 
Mobile phases consisted of water, acetonitrile, and trifluoroacetic acid at a ratio of 
90%:10%:0.1% (v:v:v) for solvent A and a ratio of 10%:90%:0.1% (v:v:v) for solvent B. A 
linear gradient was developed from 10% to 90% B within 30 min. Following lyophilization, the 
purified LGGCWGL peptide was reconstituted to 1 mg/mL in a solution of 50 mM ammonium 
bicarbonate buffer containing 20% dimethyl sulfoxide at pH 7.8 for oxidation to the disulfide. 
The oxidation reaction was allowed to proceed at room temperature, open to air, for four hours to 
form (LGGCWGL)2. The peptide was then purified using the semipreparative C18 column and 
lyophilized prior to experimentation. 
3.2.3 UV Irradiation of IgG1. IgG1 was dialyzed against water prior to use, and then 
aliquots of 500 µL IgG1 were diluted with water to a concentration of 2.3 mg/ml. The final pH 
of the non-buffered solution was 5.6. The model peptides were dissolved in water at pH 4.0 to a 
concentration of 100 µM. The solutions were saturated through head-space equilibration with 
oxygen, argon, or air for one hour in a quartz or Pyrex tube capped with a rubber stopper. Next, 
the solutions were irradiated at λ = 254 or λmax = 305 nm for up to 30 minutes in a Rayonet 
system (Southern New England, Branford, CT, RMA-500). (Actinometry gave a flux of photons 




. In Watt per cm
2
, the flux at λ=254 nm and λ=305 nm 
is ~15 W cm
-2
). Photo-irradiations at λmax = 305 nm involved four phosphor-coated low pressure 
mercury lamps (RPR-3000Ǻ) which emit predominantly between  = 285-315 nm (max = 305 
nm) and where wavelengths below 295 nm were filtered out by the use of Pyrex glass vials.  
3.2.4 UV Irradiation of Model Peptides. The GGCGGL-GGCWGL and (LGGCWGL)2 
model peptides were dissolved in water or deuterium oxide at pH 4.0 to a concentration of 100 
µM. 1 mM N-acetyl-L-tryptophanamide and 1 mM oxidized L-glutathione were added together 
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and dissolved in water to pH 7.0. The peptide solutions were saturated through head-space 
equilibration with oxygen or argon for thirty minutes in a quartz or Pyrex tube capped with a 
rubber stopper. Next, the solutions were irradiated at λ = 254 or λmax = 305 nm for up to 30 
minutes in a Rayonet system (Southern New England, Branford, CT, RMA-500). (Actinometry 




. In Watt per cm
2
, the flux at 
λ=254 nm and λ=305 nm is ~15 W cm
-2
). Photo-irradiations at λmax = 305 nm involved four 
phosphor-coated low pressure mercury lamps (RPR-3000Ǻ) which emit predominantly between 
 = 285-315 nm (max = 305 nm) and where wavelengths below 295 nm were filtered out by the 
use of Pyrex glass vials.  
3.2.5 IgG1 Enzymatic Digest. Directly after photolysis, IgG1 was denatured by 
increasing the temperature to 75˚C at a rate of 1.4˚C/minute. Following denaturation, the 
disulfide bonds in IgG1 were reduced with 0.6 mM dithiothreitol (DTT) for 30 minutes at 45˚C. 
Free thiols and amino groups were derivatized with 1.8 mM N-ethylmaleimide (NEM) for one 
hour at 37˚C and one hour at room temperature. The protein was purified by precipitation in cold 
ethanol and centrifugation for 30 minutes at 5,500 RPM at 4˚C. The pellet was reconstituted in 
ammonium bicarbonate buffer (50 mM, pH 7.8) prior to digestion. Following the addition of 20 
µg of trypsin (ratio trypsin:protein = 1:65), the samples were incubated for 2 hours at 45˚C. 
Then, 10 µg of Glu-C (ratio Glu-C:protein = 1:130) were added together with an additional 20 
µg of trypsin and the samples were incubated for an additional 5 hours at 37 ˚C, and 
subsequently stored at -20˚C until MS analysis. 
3.2.6 IgG1 Reduction of Hydroperoxides. Aliquots of IgG1 after light exposure and 
digestion were reduced with 2 mM sodium borohydride (NaBH4) at room temperature for 1 hour. 
Following the reaction, the samples were stored at 20 ˚C until MS analysis. 
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3.2.7 Measurement of Alkyl Peroxides in the GGCGGL-GGCWGL Peptide by the 
FOX2 Assay. The alkyl peroxides generated during UV light exposure of the Trp-L peptide 
were measured with the FOX2 assay, as described previously.
16,17
 Prior to measuring the alkyl 
peroxides, catalase was added to the samples to react with all the hydrogen peroxide. A solution 
of catalase was prepared at 1200 U/mL at pH 7.0 in 20 mM phosphate buffer, and added to the 
irradiated samples and non-irradiated controls in a 1:5 ratio of catalase to sample. The reaction 
proceeded at room temperature for one hour. Next, 100 µL of 0.2 M perchloric acid, 1.25 mM 
xylenol orange (XO), 0.5 mM iron (II) sulfate was pre-incubated at 4 ˚C for 15 minutes prior to 
the addition of 600 µL of 6M guanidine hydrochloride and 100 µL of sample. The samples were 
capped tight in quartz cuvettes with screw caps and the absorbance was measured at 560 nm for 
30 minutes, or until the absorbance reached a plateau. After the absorbance was recorded, the 
extinction coefficient for the Fe (III)-XO complex was determined by adding 12.5 µM iron (III) 
sulfate to the sample and recording this value after 15 minutes of reaction.  
3.2.8 LTQ-FT Mass Spectrometry Analysis. The peptides generated from the IgG1 
digest treated and non-treated with NaBH4 were analyzed by liquid chromatography-mass 
spectrometry (LC-MS) employing a Fourier-transform ion cyclotron resonance mass 
spectrometer (FT-ICR, Thermo-Finnigan, Bremen, Germany) combined with an Acquity 
chromatographer (Waters Corp., Milford, MA). The analytes were eluted from a reverse-phase 
C18 column (5 cm, 320 µm ID, CVC Microtech, Fontana, CA) at a flow rate of 20 µL/min. 
Mobile phases consisted of H2O/acetonitrile (ACN)/formic acid (FA) at a ratio of 99%:1%:0.1% 
(v:v:v) for solvent A and a ratio of 1%:99%:0.1% (v:v:v) for solvent B. The column was 
equilibrated with 1% B for 2 min. Between 2-30 min, the eluent composition was linearly 
increased to 50% B. Collision-induced dissociation (CID) data for MS/MS analysis were 
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obtained after an attenuation of the parent ion by 35%. The MassMatrix software program was 
used for peptide mapping
18
 with the IgG1 sequence provided by Amgen.  
 3.2.9 Synapt G2 Mass Spectrometry Analysis. The model peptides and photoproducts 
were analyzed on a Synapt G2 mass spectrometer (Micromass Ltd., Manchester, U.K.) combined 
with an Acquity UPLC System (Waters Corp., Milford, MA, USA). The instrument was operated 
in the data dependent acquisition (DDA) mode with all lenses optimized on the MH+ ion from 
sodium iodide. The ESI source was operated with a spray voltage of 2.5 kV, a tube lens offset of 
75 V and a capillary temperature of 250 °C. The peptides were eluted from a Grace reverse phase 
capillary C18 column with dimensions of 25 cm x 0.5 mm containing 5 μm particles (Fisher 
Scientific, Pittsburg, PA), at a flow rate of 20 µL min
-1
. The mobile phases consisted of H2O, 
acetonitrile, and formic acid at a ratio of 99.9%:0%:0.1% (v:v:v) for solvent A and a ratio of 
0%:99.9%:0.1% (v:v:v) for solvent B. A linear gradient was developed from 15% to 50% B in 
43 minutes. MassLynx software was used to acquire and analyze the data. 
3.3 Results 
 3.3.1 UV Irradiation of IgG1. During the 
exposure of IgG1 to light in an oxygen-saturated 
solution photolyzed at λ = 254 nm, fragmentation 
of Trp[191, LC] resulted in the formation of Gly 
and Gly hydroperoxide (Chart 3.1). Furthermore, 
fragmentation of Trp[309, HC] and Trp[377, HC] 
resulted in the formation of Gly[309, HC] 
hydroperoxide and Gly[377, HC], respectively. 
Chart 3.1 shows where the original Trp residues are 
Chart 3.1. IgG1 structure, where Trp[191, LC], and 
Trp[309, HC] are transformed into Gly and Gly 




located on the IgG1 molecule. 
The original Trp[191, LC] is 
located on the light chain 
(LC) sequence near intra- and 
interchain disulfide bonds and 
close to the hinge region of 
IgG1. The original Trp[309, 
HC] and Trp[377, HC] 
residues are located on the 
heavy chain (HC) sequence 
near intrachain disulfide 
bonds. The interchain 
disulfide bonds located near 
residue 191 have been 
reported to undergo 
photochemical cleavage, 
ultimately forming covalent 





 The MS/MS spectrum of the tryptic peptide sequence [178-192, LC] containing the 
Gly[191, LC] hydroperoxide is shown in Figure 3.1. In the ion series, the annotations -17 and -18 
refer to the loss of ammonia and water, respectively. The y2 and b13 ions, as well as the putative 
Figure 3.1. MS/MS spectra of the peptide sequence [178-192, LC] in IgG1 
where Trp[191, LC] is transformed into Gly[191, LC] hydroperoxide during λ 





loss of 34 Da from the b14 ion 
provide evidence for the 
replacement of the original Trp 
side-chain by a hydroperoxide. 
Interestingly, there is evidence for 
derivatization of the C-terminal 
Lys residue by NEM. In order for 
trypsin to effectively cleave the 
C-terminal lysine, the lysine 




protonation is still possible after 
NEM-derivatization, we believe 
that Lys derivatization likely 
occurred after digestion with 
some NEM left after protein 
precipitation. The NEM 
derivatization of the Lys side 
chain has been reported before.
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 The MS/MS spectrum of 
the peptide sequence [276-388, HC] containing the Gly[377, HC] product is shown in Figure 
B.1. Here, the y11, b3, and y12-17 ions provide evidence for the replacement of the original Trp 
side-chain by Gly.  
Figure 3.2. MS/MS spectra of the peptide sequence [298-314, HC] of 
IgG1 where Trp[309, HC] is transformed into Gly[309, HC] 
hydroperoxide during λ = 254 nm irradiation. (A) m/z 260-1020, bottom 




 The MS/MS spectrum of the 
tryptic peptide sequence [298-314, 
LC] containing the Gly[309, HC] 
hydroperoxide is shown in Figure 
3.2. Here, the y6, b11, and a13 ions 
provide evidence for the replacement 
of the original Trp side-chain by Gly 
hydroperoxide. In addition to this 
product formation in an oxygen-saturated system photolyzed at λ = 254 nm, Gly[309, HC] 
hydroperoxide was also detected in an air-saturated solution (ca. 20% lower yield compared to 
the oxygen-saturated solution) (Table 3.1). Importantly, Gly[309, HC] hydroperoxide formed 
upon photolysis of IgG1 with light of λmax = 305 nm in Pyrex vials (Figure B.2).   
 To confirm the hydroperoxide modification on the Gly residues, we added a reducing 
agent to the irradiated sample, sodium borohydride, NaBH4. Scheme 3.1 shows the expected Gly 
hydroperoxide products following the reduction: a hydroxide, and the amidated n-1 residue to the 
Gly hydroxide following the cleavage of the Gly hydroxide at the N-
α
C bond of the residue. 
Experimentally, we observed both the hydroxide (Figure B.3) and cleavage product in the Gly 
Scheme 3.1. Proposed reaction scheme of the fragmentation of the peptide after transformation of Trp into Gly-OOH. 
 
Table 3.1. IgG1 photoproducts formed during irradiation at λ = 254 




[309, HC] hydroperoxide 
(Figure 3.3). Figure 3.3 
shows the MS/MS spectrum 
of this cleavage product, 
showing all the b and y ions 
consistent with the new 
product. This cleavage 
product and the Gly[309, 
HC] hydroxide were not 
observed in the control 
(non-irradiated) sample. 
 It is important to 
note that hydroperoxide 
groups were detected even 
after 30 minute DTT reduction prior to tryptic digestion. However, when IgG1 was digested 
overnight, the yield of the Gly hydroperoxides was significantly reduced, likely due to a 
prolonged exposure to residual DTT. No Gly hydroperoxides were observed after sodium 
borohydride reduction, consistent with a reaction of NaBH4 with the hydroperoxides.  
 In an Ar-saturated solution, the photolysis of IgG1 at λ = 254 nm generated Gly[191, 
LC], but no hydroperoxides were detected. In addition to the formation of Gly and Gly 
hydroperoxides, we detected the formation of NFK and hydroxytryptophan, together with the 
respective unmodified peptides containing the native Trp residues. The non-irradiated controls 
showed no Trp to Gly or Gly hydroperoxide fragmentation products.  
Figure 3.3. MS/MS spectrum of the peptide sequence [298-308, HC] of IgG1 
where the n-1 amino acid (Asp) is amidated after Gly[309, HC] hydroperoxide 
was reduced with NaBH4 reduction.  
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 3.3.2 UV 
Irradiation of 
GGCGGL-GGCWGL. 
To independently confirm 
the light-induced Trp 
fragmentation, a model 
Trp-containing peptide 
connected by a disulfide 
bond was synthesized, 
GGCGGL-GGCWGL. 
This peptide was subjected 
to the same photolytic conditions as IgG1 (λ = 254 nm in an oxygen-saturated system), and we 
observed the transformation of the disulfide bond into a thiol (and derivatized with NEM) as well 
as the conversion of the Trp residue into Gly hydroperoxide (Figure 3.4). During MS/MS 
analysis, y3 and b5 fragments were detected, localizing the Gly-OOH product to the original Trp 
residue. Additionally, a b4-32 Da ion was observed, potentially indicating the loss of O2 from the 
hydroperoxide group on the original Trp residue. We also observed a loss of 34 Da (H2O2) from 
ions in this spectrum, a more common fragmentation.
22 
The b3 and y4 ions highlight the Cys 
derivatized with NEM.  
 To quantitate the peptide-bound hydroperoxide (ROOH) for our model peptide, we added 
catalase to the irradiated solution to remove H2O2 and analyzed ROOH with the FOX2 assay, as 
described previously.
 
The ratio of peak areas (hydroperoxide/native Trp-containing peptide) from 
the LC-MS and a direct comparison of the ratios of MS signal intensities for the hydroperoxide 
Figure 3.4. MS/MS spectrum of the model peptide GGCGGL-GGCWGL 




product versus the native peptide 
gave an upper limit of 3-6% of 
transformation of the native 
peptide into the hydroperoxide 
product (λ = 254 nm), consistent 
with the analysis by the FOX2 
assay which gave 6.0 ± 0.5 µM 
ROOH/ 100 µM irradiated         
peptide. An estimate for the Gly 
and Gly hydroperoxide-containing peptides formed during photo-irradiation of the antibody (λ = 
254 nm) yielded an upper limit of 10 and 40-100%, respectively, relative to unmodified peptides 
based on MS signal intensity. Confirmation of the Gly hydroperoxide yield in IgG1 by the FOX2 
assay is presently not possible because radical chain reactions and singlet oxygen chemistry may 
lead to additional hydroperoxides. 
 3.3.3 UV Irradiation of N-acetyl-L-tryptophanamide (NATA) with Oxidized L-
glutathione (GSSG). To observe the intermolecular reaction between the cleaved Trp side chain 
cleavage and an external nucleophile, a solution of 1 mM N-acetyl-L-tryptophanamide (NATA) 
was purged with O2 or Ar and irradiated at 254 nm in the presence of 1 mM oxidized L-
glutathione (GSSG) at pH 7.5 for 20 minutes. The resultant photoproducts were analyzed by LC-
MS on the Q-tof Premier. Figures 3.5A and 3.5B show the LC-MS of the photoproducts formed 
in O2 and Ar. In both chromatograms, GSSG elutes at 4 minutes and NATA elutes at ca. 13 
minutes. Only in the chromatogram of the O2-purged sample does a peak appear at ca. 12 
minutes with a m/z value of 437.1. This m/z corresponds to the reduction of the disulfide bond in 
Figure 3.5. LC-MS of irradiated N-acetyl-L-tryptophanamide with 
oxidized glutathione (GSSG): (A) under O2 and (B) under Ar. 
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GSSG to GSH and the addition of the Trp side chain (with the structures drawn in the figure). 
This hinted toward the cleavage of the Trp side chain from NATA and the trapping by the 
nucleophile GSSG, however, no MS/MS analysis was performed to confirm the structure. The 
m/z of the transformation of NATA to N-acetyl-L-glycinamide or N-acetyl-L-glycinamide 
hydroperoxide was not detected.  
 3.3.4 UV irradiation of (LGGCWGL)2. To confirm to Trp to Gly hydroperoxide with 
another model peptide, (LGGCWGL)2 was synthesized. This model peptide differed from the 
first one described, GGCGGL-GGCGWL, because Trp was synthesized in both chains, not just 
one. Therefore, if the Trp to Gly or Gly hydroperoxide is detected, there will be no ambiguity as 
to where the Gly came from. The (LGGCWGL)2 peptide was saturated separately in Ar or O2 
Figure 3.6. LC-MS of the (LGGCWGL)2 peptide (A) control (non-irradiated); (B) irradiated at λ = 254 nm under Ar for 
5 minutes; (C) irradiated at λ = 254 nm under O2 for 5 minutes. 
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and irradiated at pH 4.0 for up to 15 minutes, and analyzed by LC-MS on the Synapt G2 
instrument. 
Figure 3.6 shows representative chromatograms for the (LGGCWGL)2 peptide irradiated 
under Ar and O2 for 5 minutes at λ = 254 nm.  The LC-MS of the control peptide (Figure 3.6A) 
shows the peptide eluting at ca. 18 minutes, and small shoulder peaks on the front and tail of the 
peak, however, the side products did not affect the photoproducts generated. Figure 3.6B shows 
the LC-MS of the (LGGCWGL)2 peptide irradiated under Ar, with several new peaks appearing 
between 10 and 18 minutes of elution. Although the peaks are not fully chromatographically 
separated, the m/z values distinguish 9 major products: product 1a (m/z 574.25), 1b (m/z 
574.25), 2 (m/z 659.35), 4 (m/z 673.36), 5 (m/z 669.33), 6 (m/z 671.36), 7 (m/z 701.31), and 8 
(m/z 647.78
+2
). The LC-MS of the (LGGCWGL)2 peptide irradiated under O2 (Figure 3.6C) 
shows many of the same peaks observed during the irradiation under Ar, but the major peaks in 
the chromatogram corresponded to products not observed in the Ar-saturated samples: product 
9a (m/z 769.32), 9b (m/z 769.32), 10 (703.32), 11 (720.33
+2
), and 12 (m/z 712.33
+2
). The aim of 
this research described in this chapter was not to characterize all the photoproducts in each 
spectrum, as was the case for the work in Chapter 2. We were specifically looking for the Trp to 
Gly and/or Gly hydroperoxide product, and any novel photoproducts not observed previously. 
Additionally, since the peaks were not well separated, the MS/MS of some of the products 
included fragment ions from other peptides. To this end, we will only discuss product 1b, 2, and 
7 in the text here. Table 3.2 displays the proposed structures for these products. However, the 
proposed structures for the rest of the products, most of which are Cys H-atom transfer products 
described in Chapter 2, are displayed in Table A.1. Their respective MS/MS spectrums are 
shown in Figure A4-11.  
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i. Product 1b (m/z 574.25). 
Product 1b was observed in both 
the Ar-saturated and O2-saturated 
samples during the irradiation of 
peptide (LGGCWGL)2 at λ = 254 
nm, eluting at 12 and 11 minutes, 
respectively. The difference in 
retention times could be related to 
the additional products observed in 
the O2-saturated samples coating 
the column, changing the retention 
times of the photoproducts. Interestingly, the m/z value of product 1b, m/z 574.25, corresponded 
to the loss of the Trp side chain and the additional loss of 2 Da from the peptide. The MS/MS 
fragmentation ions in Figure 3.7 localize the loss of 2 Da to the Cys residue and the cleavage of 
the Trp side chain to Gly, however they are not traditional y and b ions. Most of the ions in the 
MS/MS spectrum contained neutral losses. When the Cys was involved in the fragment ion (i.e. 
b4 and y4 ions and greater), neutral losses of 34 Da were frequently detected from the ions, 
consistent with fragmentation of the Cys, releasing H2S from the residue. The largest ion in the 
spectrum is the loss of 34 Da from the [M+H]
+1
 ion. The Trp to Gly hydroperoxide product was 
not observed in the O2-saturated sample. 
ii. Product 2 (m/z 659.35). Product 2 was observed in both the Ar-saturated and O2-
saturated samples during the irradiation of peptide (LGGCWGL)2 at λ = 254 nm, co-eluting with 
product 3 at 12.5 minutes. The MS data indicate that the structure of product 2 is consistent with 
Table 3.2. (LGGCWGL)2 photoproducts observed after photolysis at λ 
= 254 nm. 
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the transformation of Cys into Gly. The MS/MS fragmentation b5 and y3 ions clearly show that 
the Trp is unmodified in the peptide, and the b3 and b4 ions are consistent with the 
transformation of Cys to Gly (Figure 3.8). The Trp to Gly transformation has not been observed 
before in our model peptide work. 
iii. Product 7 (m/z 659.35). Product 7 elutes at 14.8 minutes in the LC-MS (Figure 3.5), 
and is the largest photoproduct observed in the Ar-saturated irradiation of the (LGGCWGL)2 
peptide. Product 7 has a m/z value of 4 Da less than the reduced form of (LGGCWGL)2. When 
the MS/MS spectrum was analyzed, the fragmentation ions were consistent with the loss of 4 Da 
on the Cys residue, specifically the b3, b4, y3, and y4 ions (Figure 3.9). A similar product with a 
loss of 4 Da on the Cys residue, the isothiazol-3(2H)-one product, was thoroughly characterized 
in Chapter 2 following the irradiation of the (LGVCVGL)2 peptide.  




Figure 3.8. MS/MS spectrum of product 2 generated during the irradiation of (LGGCWGL)2. 




 During O2-saturated conditions, the irradiation of IgG1, GGCGGL-GGCWGL, NATA, 
and (LGGCWGL)2 resulted in the cleavage of the Trp side chain. Both Gly and Gly 
hydroperoxide were detected in place of Trp in the different model systems. Previous studies 













C bond cleavage mechanism 
of Trp involves electron transfer from the excited state Trp to the amino group, followed by the 







 The formation of the photoproducts in IgG1 likely results from a multi-step reaction: the 
photo-transformation of the disulfide bond to thiol as well as the transformation of Trp to Gly 
hydroperoxide in our model peptide suggest that the photochemistry of the disulfide bond and of 
the Trp residue need to be understood together to explain the formation of the different 
photoproducts in IgG1. The thiol results either from the one-electron reduction of the disulfide 
bond following photoionization of the Trp residue, or the homolytic cleavage of the disulfide 
bond, followed by disproportionation of the thiyl radical pair.
19,26 
In IgG1, the former is likely 
the case. We propose that, in solution, the photolytic cleavage of Trp proceeds through an 
intermediary radical cation (TrpNH
+
) and leads to a C-centered radical (Scheme 3.1). In the case 
of Trp[191, LC] and Trp[309, HC], the C-centered radical likely adds O2 followed by reaction 
with an H-donor to form the hydroperoxyl group. Instead, Trp[377, HC] was transformed into 
non-oxidized Gly[377, HC]. This Trp residue is located in the same environment as Trp[309, 
HC], so O2 should have been available for oxidation, but the C-centered radical intermediate 
likely reacted faster with an H-atom donor, such as a thiol, than with O2. The effect of oxygen on 
product formation can be rationalized in multiple ways. Certainly, oxygen is important for the 
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formation of the Gly hydroperoxide. 
However, oxygen may also function 
as an acceptor of the electrons 
photoejected from Trp, limiting a 
potential back reaction to restore the 
reactants. The final product yield may 
also be affected by intramolecular 
electron transfer reactions between 
tryptophan radical cations and 
electron donors such as tyrosine.  
 Interestingly, when the Trp 
side chain was cleaved in N-acetyl-L-tryptophanamide (NATA) in the presence of a nucleophile, 
oxidized glutathione, the side chain was trapped by the glutathione. This reaction product is 
important because in a protein, if the Trp side chain is cleaved, there are many available 
nucleophiles that could trap the Trp side chain. This could greatly affect the protein if the 
conformation was modified, especially if it the trapping amino acid was located in a region 
involved in binding or recognition. 
 The irradiation of (LGGCWGL)2 did not yield a Gly hydroperoxide when the Trp side 
chain was cleaved in O2, as expected from the results with the model peptide GGCGGL-
GGCWGL. However, a product with Trp to Gly combined with Cys thioaldehyde was observed, 
product 1b. The MS/MS fragmentation of this product (Figure 3.7) was not as straight-forward 
as the MS/MS fragmentation of the Gly hydroperoxide product in GGCGGL-GGCWGL (Figure 
3.4). The MS/MS data for product 1b contained many neutral losses and water (-18), ammonia (-
Scheme 3.2. Proposed reaction scheme demonstrating the 




17), and H2S (-34). Although these neutral losses are easily explained, their ion intensity 
compared to the native ions (i.e. b4, b5) is very high. This could be due to the conformation of 
the peptide, allowing these neutral losses so easily, or the structure assigned to product 1b could 
be misguided. The structure could actually correspond to a peptide modification somewhere else 
on the molecule, freeing up an amine or thiol for more facile cleavage. What is most interesting 
about the irradiation of this peptide is product 7, where we hypothesize another isothiazol-3(2H)-
one product could be formed, just as with the (LGVCVGL)2 peptide from Chapter 2. In Chapter 
2, we proposed that the steric hindrance of the Val residues to the i+1 and i-1 residue of the Cys 
were the reason for this product formation, since no such product was observed in peptides with 
Gly or Ala in these positions.  The Trp reside in the (LGGCWGL)2 peptide studied in this 
chapter does have a Trp residue next to the Cys, and this could have the same effect as the Val 
residues had on the steric conformation of the molecule. Whereas the isothiazol-3(2H)-one 
product in Chapter 2 was the main product generated in 90% yields, with the Trp-and disulfide 
containing peptide it is not. This is likely because the Trp absorbs most of the light energy, not 
the disulfide bond. It would be interesting to modify the irradiation conditions with the Trp and 
disulfide containing peptide to see if higher yields of this product could form.   
3.5 Conclusion 
 The amino acid hydroperoxide represents not only a significant chemical alteration, but 
could serve as origin for further protein oxidation. For example, amino acid hydroperoxides have 
been shown to inactivate proteins via oxidation of Cys residues.
13
 Our work also demonstrates 
that light exposure, and subsequent radical formation produces Gly hydroperoxides at λmax = 305 
nm, i.e. wavelengths not filtered out by glass. The conversion of Trp to Gly and Gly 
hydroperoxide converts an aromatic amino acid into a small, highly flexible aliphatic amino acid 
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(or its hydroperoxide derivative). These alterations may in part rationalize the loss of 
conformational integrity observed during photo-irradiation of the antibody, quantified through 
biophysical measurements.
27
 Further mechanistic experiments with (LGGCWGL)2 and 
(LGCGWGL)2 are needed to characterize the influence of peptide/protein sequence and structure 
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Figure B.1. MS/MS spectra of the peptide sequence [376-388, HC] of IgG1 where Trp[377, HC] 
is transformed into Gly[377, HC] during 254 nm irradiation. (Top spectrum: m/z 200-750, 
































Figure B.2. MS/MS spectra of the peptide sequence [298-314, HC] of IgG1 where Trp[309, HC] 
is transformed into Gly[309, HC] hydroperoxide during 305 nm irradiation. (Top spectrum: m/z 

































Figure B.3. MS/MS spectra of the peptide sequence [298-314, HC] of IgG1 where Trp[309, HC] 
is transformed into Gly[309, HC] hydroxide after NaBH4 reduction. (Top spectrum: m/z 260-



























Figure B.4. MS/MS spectra of product 3, generated during the photolysis of (LGGCWGL)2 at λ 
= 254 nm. 
 
Figure B.5. MS/MS spectra of product 4, generated during the photolysis of (LGGCWGL)2 at λ 

































Figure B.6. MS/MS spectra of product 5, generated during the photolysis of (LGGCWGL)2 at λ 
= 254 nm. *Represents fragment ions of oxidized Trp residue (not from product 5). 
 
Figure B.7. MS/MS spectra of product 6, generated during the photolysis of (LGGCWGL)2 at λ 

































Figure B.8. MS/MS spectra of product 9a/9b, generated during the photolysis of (LGGCWGL)2 
at λ = 254 nm. 
 
Figure B.9. MS/MS spectra of product 10, generated during the photolysis of (LGGCWGL)2 at λ 




















Chapter 4. Photo-oxidation of model peptides: Formation of triply oxidized 
































A great amount of work has been published on protein oxidation and its effect on protein 
stability, especially since all amino acids have the potential to oxidize.
1,2,3
 Oxidation is often 
initiated by light exposure or reactive oxygen species generated by metal-catalyzed oxidation 
(MCO).
4,5
 In therapeutic proteins such as monoclonal antibodies (mAbs), the most common 
oxidation products are detected on the Trp and Met residues, although His, Cys, Tyr, and Phe are 
also targets for oxidation.
6,7,8,9
 The oxidation of these residues has been reported to effect the 
efficacy and stability of the entire protein, thereby reducing shelf-life and drug safety. For 
instance, Trp oxidation in the complementarity-determining region (CDR) was reported to 
significantly reduce antigen binding and biological activity in an IgG1 monoclonal antibody 
following UV light exposure.
7
 Methionine oxidation in the neonatal Fc (fragment crystallizable) 
receptor (FcRn) region shortened serum half-life
10
 and reduced binding affinity to the FcRn 
receptors.
11
 Oxidation of His, Met, and Trp in IgG2 was observed after MCO with Cu(II) and 
ascorbate, leading to changes in both the secondary and tertiary structure.
12
 His oxidation has 
also been reported in human growth hormone by both light
13
 and MCO (with Cu(II) and 
ascorbate) in regions located in the metal binding site.
14,15
 
Recently, novel protein modifications have been observed for His and Trp residues. 
Doubly oxidized His[289, HC] (i.e. hydroxylated imidazolone) was reported in the Fc region of 
IgG1 using mass spectrometry (MS) analysis.
16
 This oxidation was only detected after light 
stress (2000 lux hours of visible light at 25 °C with 65% relative humidity (RH) for 25 days), not 
thermal stress conditions (40 °C with 75% relative humidity (RH) for 3 months); therefore, it 
was proposed that the oxidation was initiated by singlet oxygen.
5
 In separate IgG1 molecules, the 
same His residue was triply and doubly oxidized after exposing IgG1 to ICH light stress 
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conditions (1.2 million lux hours of visible light and 200 Watt hours/m
2
 of UV light during 24 
hours, unpublished data). Singlet oxygen was also proposed to initiate a His-His crosslink in 
photo-oxidized IgG1, detected through 
18
O-labeling and MS analysis using the XChem-Finder 
crosslinking software program.
17
 The crosslink was observed between two separate His[220, 
HC] amino acids, with the crosslink proposed between one His imidazole N-1 atom and a 
separate imidazole C-4 atom. Furthermore, light exposure of IgG1 in the presence of oxygen 
converted the Trp to Gly and Gly hydroperoxide (Chapter 3).
18
 A similar Trp side chain cleavage 
was observed when the synthetic analogue of the peptide hormone somatostatin, octreotide, was 
photo-irradiated.
19
  One of the major differences between somatostatin and octreotide is the 
amino acid configuration of the Trp residue: L-Trp in somatostatin and D-Trp in octreotide. Due 
to the D-Trp configuration in octreotide, the distance between the carbonyl group of the D-Trp 
and the disulfide bond in the peptide is only 4.5 Å, whereas in somatostatin, the distance between 
the carbonyl of the L-Trp and the disulfide bond is 7.8 Å. Following exposure of both peptides to 
UV and cool white light, somatostatin was relatively inert to photodegradation, while the D-Trp 






in octreotide was converted to a hydroxyl group, and the resultant Trp side chain (3-
methyleneindolenine, i.e. 3-MEI) was abstracted by the nearby Lys in the peptide (Scheme 4.1). 
These novel photoproducts highlight the importance of continued research in protein stability, 
and particularly photostability.   
To understand the His degradation pathway more fully and determine the role of Trp 
photosensitization, model peptides were synthesized for peptides where His oxidation has been 
observed, and for comparison, mutant peptides were synthesized in which Ala was substituted in 
place of Trp. Interestingly, after photo-irradiation of the peptides, MS analysis revealed a triply 
oxidized His residue on one of the Ala-containing peptides, but not the Trp-containing peptides. 
However, an isobaric product with the same m/z value to the native peptide was detected in a 
Trp-containing model peptide, and further experimentation determined that Trp was converted to 
Gly and the N-terminal Lys had abstracted the resultant Trp side chain (3-MEI). Moreover, when 
the Lys amine was methylated prior to irradiation to inhibit the reaction with 3-MEI, an isobaric 
product was detected again, albeit the Tyr residue was responsible for abstracting the 3-MEI 
group. Only when both the Tyr and Lys residues were acetylated to inhibit reactions with the 
photolytically generated 3-MEI group were no isobaric products observed.  This could indicate 
that Trp radical cations do not cleave if there is not an acceptor for 3-MEI or they are re-attached 
to the Trp, re-forming the original Trp residue. 
4.2 Experimental methods 
4.2.1 Materials. Ammonium bicarbonate, dimethyl sulfoxide (DMSO), sodium 
borohydride (NaBH4), sodium hydroxide, sodium phosphate monobasic, sodium phosphate 
dibasic, L-glutathione oxidized (GSSG), acetic anhydride, and trypsin (from porcine pancreas) 
were supplied by Sigma-Aldrich (St. Louis, MO) at the highest commercially available purity. 
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Sequencing grade Glu-C and trypsin were purchased from Promega (Madison, WI). N-
succinimidyl acetate was supplied by TCI America (Portland, OR), and formaldehyde (37%) was 
supplied by Amersham Biosciences (Piscataway, NJ). The model peptides, Ac-
KTVLHQDWLNGK-Am (H318W), Ac-KTVLHQDALNGK-Am (H318A), Ac-
KNWYVDGVEVHNAK-Am (H293W), and Ac-KNAYVDGVEVHNAK-Am (H293A), were 
provided by a pharmaceutical company. 
4.2.2 Methylation of the Lys Residues in H293W. Reductive methylation of the 
H293W Lys residues was accomplished with formaldehyde and NaBH4.
20
  Briefly, 1M NaBH4 in 
200 mM sodium borate buffer and 1M formaldehyde in 200 mM sodium borate buffer were 
freshly prepared and placed on ice for the duration of the reaction. The peptide was prepared at a 
concentration of 1 mg/mL in 200 mM sodium borate buffer at pH 8.5. To the solution, final 
concentrations of 30 mM formaldehyde and 6 mM NaBH4 were added and the solution was 
stirred at 0 ˚C on ice. After 10 minutes of reaction, another 3 mM NaBH4 was added and the 
solution stirred at 0 ˚C on ice for an additional 20 minutes. These steps were repeated three 
times, and a final addition of 6 mM NaBH4 was added to the samples. To quench the reaction, a 
final concentration of 2.5 mM Gly containing 0.1% formic acid (v/v) was added to the solution. 
The buffer and residual reagents were removed from the methylated peptide with an HPLC 
purification step gradient method on a Shimadzu SCL-10A instrument. A C18 Grace Vydac 
218TP guard column with dimensions of 7.5 x 4.6 mm ID, containing 5μm particles (Fisher 
Scientific, Pittsburg, PA) was used. The mobile phases consisted of H2O and acetonitrile at a 
ratio of 95%:5% (v:v) for solvent A and a ratio of 5%:95% (v:v) for solvent B. At a flow rate of 
1 ml/min, 100% solvent A was maintained for five minutes and then switched to 100% solvent B 
for peptide elution. The collected solution was lyophilized and reconstituted in water to a 
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concentration of 100 μM (as determined using the Beer-Lambert law after measuring the 
absorbance of the solution at 280 nm in a Cary 50 Bio UV-Visible spectrometer (Varian Inc., 









, respectively). The pH was adjusted to pH 4.5 with 0.1 M HCl. The methylation 
was confirmed by mass spectrometry using the Q-tof Premier mass spectrometer (See section 
4.2.11). 
4.2.3 Acetylation of the Lys and Tyr Residues in H293W. Acetylation of the Lys and 
Tyr residues was accomplished using N-succinimidyl acetate (NSA).
21
 A stock solution of NSA 
was prepared at 500 mM in DMSO. 20 µL of the stock solution of NSA was mixed with 25 µL 
of 200 µM H293W peptide and 55 µL of 50 mM pH 9.0 phosphate buffer. The reaction mixture 
was incubated at room temperature for 15 minutes. The NSA and phosphate buffer were 
removed from the acetylated peptides with an HPLC purification step gradient method on a 
Shimadzu SCL-10A instrument. A C18 Grace Vydac 218TP guard column with dimensions of 
7.5 x 4.6 mm ID, containing 5μm particles (Fisher Scientific, Pittsburg, PA) was used. The 
mobile phases consisted of H2O and acetonitrile at a ratio of 95%:5% (v:v) for solvent A and a 
ratio of 5%:95% (v:v) for solvent B. At a flow rate of 1 ml min
-1
, 100% solvent A was 
maintained for five minutes, then changed immediately to 100% solvent B for peptide elution. 
The collected solution was lyophilized and reconstituted in water to a concentration of ca. 100 
μM. The acetylated peptides were separated using a YMC-Pack ODS-A C18 reverse phase 
column with dimensions of 250 x 4.6 mm ID containing 5μm particles (YMC America, Inc. 
Allentown, PA). The mobile phases consisted of H2O, acetonitrile, and trifluoroacetic acid at a 
ratio of 95%:4.9%:0.1% (v:v:v) for solvent A and a ratio of 4.9%:95%:0.1% (v:v:v) for solvent 
B. A linear gradient was developed by increasing solvent B from 10% to 45% in 25 minutes with 
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a flow rate of 1ml/min. The collected solution was then lyophilized and reconstituted in water to 
a concentration of 100 μM (as determined using the Beer-Lambert law after measuring the 
absorbance of the solution at 280 nm in a Cary 50 Bio UV-Visible spectrometer (Varian Inc., 









, respectively). The pH was adjusted to pH 4.5 with 0.1 M HCl. The acetylation 
was confirmed by mass spectrometry using the Q-tof Premier mass spectrometer (See Section 
4.2.11). 
4.2.4 UV Irradiation of Model Peptides. Peptides were dissolved in water at pH 4.0 to a 
concentration of 100 µM. The solutions were O2-saturated through head-space equilibration with 
O2 for up to thirty minutes in quartz tubes capped with rubber stoppers. The samples were then 
exposed at room temperature to light for up to thirty minutes at λ = 254 nm in a Rayonet RPR-
200 photoreactor equipped with four phosphor-coated low pressure mercury lamps, RPR-2537, 
and a RMA-500 Merry-Go-Round unit (Southern New England, Branford, CT, RMA-500). 
Actinometry measurements for the λ = 254 nm lamp gave a flux of 2.96 x 10
-4
 einstein/min and 
irradiance of ~15 W cm
-2
. Directly after photolysis, samples were frozen at -20 °C until MS 
analysis.  
4.2.5 UV Irradiation of H293W and Oxidized L-glutathione. A final concentration of 
100 µM oxidized L-glutathione (GSSG) was added to 100 µL of 100 µM H293W at pH 7.0 in 
water. The solution was saturated through head-space equilibration with oxygen for thirty 
minutes and then irradiated at  = 254 nm for twenty minutes, and frozen at -20 °C until MS 
analysis. 
4.2.6 Glu-C Digestion of H293W and H293A. Following the irradiation of H293W and 
H293A, the peptides were digested with freshly prepared Glu-C in a 1:20 ratio of enzyme to 
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peptide in 50 mM ammonium bicarbonate buffer at pH 7.8. The samples were placed in a 37 °C 
incubator overnight and subsequently frozen at -20 °C until MS analysis. 
4.2.7 Tryptic Digestion of H293W. Trypsin (from Promega and Sigma-Aldrich) was 
diluted to a concentration of 1 mg/mL with 1 mM HCl and 20 mM CaCl2, aliquoted, and stored 
at -20 °C until needed. Then, the enzyme from each supplier was added separately to peptide 
samples separately in a 1:20 enzyme to peptide ratio, and the pH of the solution was adjusted 
with ammonium bicarbonate (50 mM, pH 7.8). The samples were placed in a 37 °C incubator for 
four hours, and frozen at -20 °C until MS analysis. 
4.2.8 LTQ-FT Mass Spectrometry Analysis. The peptides were analyzed on a linear 
trap quadrupole-Fourier transform (LTQ-FT) ion cyclotron resonance mass spectrometer 
(Thermo-Finnigan, Bremen, Germany) equipped with a NanoAcquity UPLC System (Waters 
Corp., Milford, MA, USA). The instrument was operated in a data-dependent acquisition mode 
with all lenses optimized on the MH+ ion from leucine enkephalin. The ESI source was operated 
with a spray voltage of 2.8 kV, a tube lens offset of 96 V and a capillary temperature of 200 °C. 
The peptides were eluted from a reverse phase non-porous Imtakt Presto FF-C18 column with 
dimensions of 15 cm x 0.5 mm ID containing 2 µm particles (Imtakt Corp., Philadelphia, PA, 
USA), at a flow rate of 5 µL min
-1
. The mobile phases consisted of H2O, acetonitrile, and formic 
acid at a ratio of 99.9%:0%:0.1% (v:v:v) for solvent A and a ratio of 0%:99.9%:0.1% (v:v:v) for 
solvent B. A linear gradient was developed by increasing solvent B from 3% to 40% in 50 
minutes. The XCalibur software was used to acquire and analyze the data.  
4.2.9 Q-Tof Mass Spectrometry Analysis. The peptides were analyzed by a Micromass 
Q-Tof Premier mass spectrometer (Micromass Ltd., Manchester, U.K.) equipped with an 





 mode with all lenses optimized on the MH+ ion from sodium iodide. The ESI source was 
operated with a spray voltage of 2.5 kV, a tube lens offset of 75 V and a capillary temperature of 
250 °C. The peptides were eluted from a Grace reverse phase capillary C18 column with 
dimensions of 25 cm x 0.5 mm containing 5 μm particles (Fisher Scientific, Pittsburg, PA), at a 
flow rate of 20 µL min
-1
. The mobile phases consisted of H2O, acetonitrile, and formic acid at a 
ratio of 99.9%:0%:0.1% (v:v:v) for solvent A and a ratio of 0%:99.9%:0.1% (v:v:v) for solvent 
B. A linear gradient was developed by increasing solvent B from 15% to 50% in 43 minutes. The 
MassLynx software was used to acquire and analyze the data. 
4.3 Results  
  4.3.1 His and Trp Modifications observed in the Model Peptides. To elucidate the 
mechanism of triple His oxidation in IgG1, model peptides were synthesized to represent the 
tryptic peptides in IgG1 where His oxidation was observed. The peptides either contained Trp 
residues or for comparison, the Trp was replaced with Ala to examine the role of Trp 
photosensitization in His oxidation. The model peptides contained an N-acetyl Lys and a C-
terminal Lys amide residue to aid in solubility. The following peptides were synthesized: Ac-
KNWYVDGVEVHNAK-Am (H293W), Ac-KNAYVDGVEVHNAK-Am (H293A), Ac-
KTVLHQDWLNGK-Am (H318W), and Ac-KTVLHQDALNGK-Am (H318A). The model 
peptides were photo-irradiated for 20 minutes in oxygen-saturated water, pH 4.0, with λ = 254 
nm, and subsequently analyzed with the LTQ-FT MS instrument. The resultant photoproduct 
yields are summarized in Table 4.1. The yields were measured by LTQ-FT signal intensity and 
shown as the relative intensity of the products divided by the intensity of the native parent ion. 
LTQ-FT signal intensity is not the best way to quantify peptides because this quantitation 
assumes all peptides are ionized (and therefore detected) at a similar level, but this is not always 
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a reasonable assumption. However, because we wanted to distinguish the oxidation of His from 
that of Trp and Tyr in our peptides, we needed high-resolution MS/MS data, which the LTQ-FT 
MS does provide. The MS data revealed that His was not oxidized to a great extent in any of the 
photo-irradiated model peptides, as was expected due to the low yields of His oxidation observed 
in mAb A.  The H293A peptide showed only transformation of His to Asn in a 1% yield, 
whereas the H318A peptide showed modifications of His to Asn and Asp, and mono and tri-
oxidation of His at yields of 1.3%, 0.4%, 1.2%, and 3.2%, respectively. The conversion of His 
into Asp and Asn has been reported previously.
22
 The MS/MS characterization of the triply 
oxidized His residue in the H318A peptide will be described below.  It was interesting to detect 
triply oxidized His after irradiation for the mutant H318A peptide because this was not the 
peptide modeled after the triply oxidized His in mAb A. Following photo-oxidation of the Trp-
containing peptide H318W, a small yield of the His to Asn (0.2%) and Asp (0.4%) products, and 
mono-oxidized His was observed (0.1%). The H293W peptide did not show much His oxidation, 
Table 4.1. The relative intensity (by MS signal intensity) of the degradation photoproducts observed after irradiation 




except the conversion of His to Asn (0.5%) and Asp (0.4%). Besides His oxidation, the Ala-
containing peptides, H293A and H318A, were not efficiently photo-oxidized and did not show 
other degradation products. However, there was significant Trp oxidation in the Trp-containing 
peptides, H293W and H318W. The H318W peptide was most susceptible to photo-oxidation. 
Kynurenine (Ky), N-formylkynurenine (NFK), and two hydroxytryptophan products were 
detected in high yields: 11.6%, 18.8%, 15.8% and 13.6%, respectively. The two 
hydroxytryptophan products eluted at different retention times, but since they were isobaric in 
mass, the location of the hydroxyl group on the Trp could not be determined. Another 
uncommon Trp degradation product was observed in a 1.6% yield after H318W irradiation, the 
conversion of Trp to Asp. To our knowledge, this degradation product has not been reported 
during the photodegradation of peptides before, but evidence for conversion of Trp to Asp has 
been documented for the oxidant ruthenium (VIII) oxide.
23
 The MS/MS spectrum of this 
product, compared to the control peptide is presented in Appendix C, Figures C.1 and C.2, 
respectively. Following irradiation, the H293W peptide was oxidized to Ky, hydroxytryptophan, 
and NFK in yields of 7.3%, 13.8%, and 5.3%, respectively. The yields of these Trp oxidation 
products were an order of magnitude higher than the His oxidation products. Interestingly, the 
largest yielding degradation product was not a common Trp oxidation product, but a Trp side 
chain cleavage product (with a yield of 18.6%), notated from here on as product 1. More detailed 
characterization of product 1 and of the underlying reactions will be presented in Section 4.3.2.  
The extracted ion chromatograms (XIC) of the H318A peptide and of its triply oxidized 
His product are shown in Figure 4.1. The non-modified model peptide, with m/z 1364.76, elutes 
at 6 minutes in both the control (Figure 4.1A) and the photo-irradiated sample (Figure 4.1B). 
Photo-irradiation leads to a new product, eluting at 7.6 minutes, with m/z 1412.76, i.e. a product 
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48 Da heavier than the 
control peptide. The 
MS/MS spectrum of the 
control, non-modified 
H318A peptide is 
shown in Figure 4.2. 
The most intense 
fragment ion detected 
was the doubly charged 
[M+2H]
+2
-17 ion, i.e. 
the molecular ion, 
which has lost one 
Figure 4.1. Extracted ion chromatograms (XIC) of the H318A model peptide in the (A) control and (B) irradiated 
sample ( = 254 nm) in water at pH 4.0. 
ICH light stressed samples. 
 
 





ammonia molecule. The 
b4, b5, y7, and y8 ions 
show no oxidation on 
the His residue. The 
MS/MS spectrum of the 
oxidized product 
(Figure 4.3) shows a 
similar high intensity 
fragment ion 




-17 ion. The b4 and y7 ions show no change in m/z values compared to the unmodified 
peptide, but the b5 and y8-17 ions, show an increase of 48 Da  relative to the native, unmodified 
peptide, localizing the oxidation solely to the His residue. This spectrum was also shows that 
when the His is in the fragment ions (i.e. b5-b11 and y7-y11), neutral losses of water or ammonia 
were commonly observed.  
4.3.2 Characterization of Product 1 Formation in H293W.  Interestingly, by LC-MS 
analysis on the LTQ- FT instrument, the most prevalent product following photo-irradiation of 
H293W at λ = 254 nm was a product isobaric in mass to the native H293W peptide (product 1). 
In the following, we will demonstrate that in product 1, Trp is converted to Gly and the N-
terminal Lys abstracts the resultant Trp side chain (3-methyleneindolenine, i.e. 3-MEI). The 
proposed structure is presented in Table 4.2.    
Figure 4.3. MS/MS spectrum of the triply oxidized H318A model peptide formed 





i. Glu-C Digestion of H293W and H293A. To first determine whether His or Trp was 
involved in product 1 formation, the two amino acids in peptide H293W were separated into two 
peptides after the photo-oxidation of H293W. The Glu-C enzyme is ideal for separating the His- 
and Trp-derived products after photo-irradiation because Glu-C cleaves preferentially C-terminal 
of Glu in ammonium bicarbonate buffer, i.e. C-terminal of the Glu residue located between Trp 
and His in H293W. Therefore, the H293W peptide (Ac-KNWYVDGVEVHNAK-NH2; m/z 
1699.8) was fragmented into two smaller peptides: Ac-KNWYVDGVE (m/z 1151.4) and 
VHNAK-NH2 (m/z 567.4). Likewise, the H293A peptide (Ac-KNAYVDGVEVHNAK-NH2; 
m/z 1584.8) was fragmented into two smaller peptides: Ac-KNAYVDGVE (m/z 1036.4) and 
VHNAK-NH2 (m/z 567.4).  
H293A and H293W were dissolved in water to a concentration of 100 µM at pH 4.0, 
saturated with O2, and irradiated at λ = 254 nm for 20 minutes. The irradiated samples and 
control (non-irradiated) samples were adjusted to pH 7.8 with 50 mM ammonium bicarbonate 
buffer and digested with Glu-C overnight at 37 °C. The resultant products were then analyzed by 
LC-MS using the Q-tof Premier and MS/MS using the LTQ-FT instrument.   
 For clarity, Figure 4.4 shows the XIC of the control and photo-irradiated peptides 
H293W and H293A, displaying only the m/z values associated with the respective Ac-
KNWYVDGVE sequences obtained by Glu-C digestion. The H293W control (Figure 4.4B) 
elutes at 9 minutes, and there is no other peak in the chromatogram; however, photo-irradiation 




of H293W (Figure 4.4A) 
generates an additional 
peak eluting at 7 minutes 
(product 1). MS analysis 
reveals that both peaks 
contain peptides with 
identical m/z values, i.e. 
the new peak eluting at 7 
minutes appears to be an 
isobaric product. (Note: An isobaric product in mass spectrometry is defined as atomic or 
molecular species with the same nominal mass but different exact masses.
24,25
) Figures 4.4D and 
4.4C show the XIC of control and photo-irradiated H293A, respectively. Both chromatograms 
contain only one peak that elutes at 5 minutes, with the expected m/z value for the Ac-
KNWYVDGVE sequence. The VHNAK-NH2 sequence of the digested H293W and H293A 
peptides eluted at ca. 3.8 minutes in the LC-MS (data not shown). A comparison between the 
Glu-C digested peptides H293W and H293A shows that the product 1 is derived from Trp. When 
Trp was replaced by Ala, no isobaric product was observed. The MS/MS analysis of the native 
Ac-KNWYVDGVE peptide eluting at 9 minutes and product 1 eluting at 7 minutes in Figure 
4.4A are shown in Appendix C, Figures C.3 and C.4, respectively.   
Figure 4.4. Extracted ion chromatograms (XIC) from model peptides before and 
after irradiation at  = 254 nm in water at pH 4.0: (A) H293W after light 





ii. Kinetics of Product 1 
Formation. After confirming that 
Trp was the amino acid involved in 
product 1 formation, experiments 
were then conducted without the use 
of Glu-C digestion. Although the 
Glu-C digest worked to separate the 
His and Trp into two peptides after 
photo-oxidation, it was an 
unnecessary, cost-prohibitive step in 
the analysis after the initial experiment to determine whether His or Trp was the amino acid 
involved in product 1 formation.  
H293W was photo-irradiated at λ = 254 nm in water at pH 4.0 for up to 30 minutes after 
O2-saturation. The samples were then analyzed by LC-MS/MS using the Q-tof Premier 
instrument. Figure 4.5 shows the kinetics of product 1 formation as the yield increases in a 
biphasic mode, a slower process between 0 and 20 minutes, and a faster process after 20 minutes, 
to a yield of about 25% within 30 minutes. For the rest of our experiments, we chose to photo-
irradiate the peptide for 20 minutes, where about 10% of H293W were converted to product 1. 
The MS/MS spectra obtained from the Q-tof Premier of the control H293W peptide and product 
1 is presented in Figures 4.6 and 4.7, respectively. Both spectra were enlarged by 2-fold for 
clarity because the His and Lys immonium ions were of greater intensity than the other m/z ions. 
The spectra of the control peptide (Figure 4.6) shows all the fragment ions associated with 
unmodified amino acids, and specifically, all the fragments on the N-terminal portion of the 
Figure 4.5. Kinetics of the product 1 formation after irradiation of 
H293W at  = 254 nm in water at pH 4.0 for up to 30 minutes as 






















Irradiation time (minutes) 
Product 1 Kinetics 
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peptide: b1, b2, b3, and b4. 
Importantly, the Trp immonium 
ion is observed with m/z 159.10. 
Figure 4.7 displays the MS/MS 
spectrum of product 1, which 
looks very similar to the MS/MS 
spectrum of the control H293W 
peptide, except for the absence 
of the b1, b2, or b3 ions and the 
Trp immonium ion. Instead, 
internal fragment ions 
corresponding to GY and NGYV 
(m/z 434.23) were observed. 
Since there was initially no 
sequential GY in the peptide 
sequence, we can assume this 
fragmentation ion is indicative 
of the Trp side chain cleavage 
and conversion to a Gly residue, 
however the m/z 434.23, 
assigned to the NGYV sequence, 
is observed in the MS/MS 
spectrum of the control peptide, 
Figure 4.6. MS/MS spectrum of the control H293W peptide.   
 
Figure 4.7. MS/MS spectrum of product 1 generated by the irradiation 





so this ion could have a different structure. The MS/MS spectrum in Figure 4.7 is not clearly 
indicative of the Trp side chain cleavage since no b ions were observed supporting the movement 
of the Trp side chain, just the absence of b ions. However the differences between the MS/MS 
spectra in product 1 compared to the control H293W peptide were significant enough for us to 
form the hypothesis that the Trp side chain was cleaved, Gly formed in its place, and Lys trapped 
the resultant Trp side chain. 
iii. Tryptic Digestion of H293W. To determine if the N-terminal Lys had indeed trapped 
the Trp side chain, we wanted to separate the N-terminal Lys from the rest of the peptide by 
tryptic digestion. If the Trp side chain is connected to the N-terminal Lys amine group, trypsin 
will most likely not recognize the amino acid as a substrate and no Lys cleavage will occur in 
product 1. Conversely, if the N-terminal Lys does not contain the Trp side chain (like the control, 
non-irradiated), the Lys group in product 1 will be cleaved during the digestion. The tryptic 
digestion was accomplished with two different sources of trypsin: sequencing grade from 
Promega and non-sequencing grade from Sigma-Aldrich. The trypsin from Sigma-Aldrich also 
contained chymotryptic activity, therefore cleaving C-terminal of the Lys and Tyr, Trp, and His 
residues, adding complexity to the analysis.  
Following the irradiation of the H293W peptide, the pH of the solution was adjusted to 
pH 7.8 with ammonium bicarbonate buffer. Trypsin (both types) was added to samples in a 1:20 
enzyme to protein ratio and incubated at 37 °C for four hours. Figure 4.8 shows the LC-MS of 
the control (non-irradiated) H293W peptide (Figure 4.8A), the irradiated sample (Figure 4.8B), 
and the irradiated sample after digestion with the Promega trypsin (Figure 4.8C). Figure 4.8A 
only contains one peak with the doubly charged ion m/z 850.40
+2
 at 20 minutes associated with 
the control H293W peptide. In Figure 4.8B, the native peptide elutes around 21.5 minutes, 
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although the MS/MS spectrum is identical to that of the control. In addition, three new peaks 
elute at 19.2, 19.5, and 19.8 minutes. The peak at 19.2 minutes corresponds to product 1, and the 
peaks at 19.5 and 19.8 minutes correspond to Trp mono-oxidation products. Figure 4.8C shows 
the LC-chromatogram after trypsin digestion, where there are no longer any isobaric products 
observed. Now, there are only two major peaks, and a shoulder on the first peak. The first peak 
elutes at 19.8 minutes with a m/z 850.95
+2
, a gain of 1 Da compared to the native H293W 
peptide, corresponding to deamidation of the amidated C-terminal. The shoulder on the first peak 
contains ions with m/z 773.89
+2
, corresponding to the mono-oxidation of the Trp residue, 
cleavage of the N-terminal Lys, and deamidation. The second peak, eluting at 21.2 minutes, 
contains a product with a m/z of 765.88
+2
. This m/z value corresponds to the cleavage of the N-
Figure 4.8. LC-MS chromatogram of the H293W peptide (A) control; (B) irradiated sample; (C) irradiated 





terminal Lys and deamidation of the native H293W peptide. The MS/MS spectrum of the m/z 
765.88
+2 
product eluting at 21.2 minutes is displayed in Figure 4.9. The fragmentation ions are 
indicative of an unmodified H293W peptide with no N-terminal Lys or C-terminal amine group, 
the product expected from a tryptic digest. Although no b1 ion is observed, the Trp immonium 
ion is detected (m/z 159.11), as observed in the control H293W peptide spectrum in Figure 4.6. 
The MS/MS spectrum of the m/z 850.95
+2 
product eluting at 19.8 minutes is displayed in Figure 
4.10. Importantly, the observed b1 ion (m/z 300.13) matches the predicted m/z value of a Lys 
residue attached to 3-methyleneindolenine (3-MEI), i.e. the Lys attached to the Trp side chain, as 
is the predicted structure of product 1. The rest of the fragment ions match closely to the MS/MS 
spectrum observed in non-digested product 1 (Figure 4.7), except with the addition of 1 Da to all 
Figure 4.9. MS/MS spectrum of the m/z 765.88
+2
 peak observed after the digest of the irradiated H293W peptide, 





the y-ions because of the C-terminal deamidation. The inability of the trypsin to digest the 
isobaric product, along with the b1 ion corresponding to Lys attached to 3-MEI was enough 
evidence to conclude that during the photo-oxidation of H293W, the Trp side chain was cleaved 
and trapped with the N-terminal Lys residue in product 1. The tryptic digest using the Sigma-
Aldrich trypsin showed similar results, except many other chymotryptic fragments were 
observed, so it is presented and explained in Figure C.5. 
iv. Trapping 3-methyleneindolenine (3-MEI) with Oxidized L-glutathione (GSSG). To 
trap the resultant Trp side chain, 3-MEI, before the Lys amine can react with it and form product 
1, oxidized L-glutathione (GSSG) was added to the H293W sample prior to irradiation at  = 
254 nm. 100 µM oxidized glutathione was added in a 1:1 ratio with the H293W peptide. The 
Figure 4.10. MS/MS spectrum of the m/z 850.95
+2
 peak observed after the digest of the irradiated H293W peptide, 





sample was then saturated 
with oxygen, irradiated at 
pH 7.0 in water for twenty 
minutes, and then frozen 
at -20 °C until mass 
spectrometry analysis. The 
sample was irradiated at 
pH 7.0 so the equilibrium 
was shifted towards the 
nucleophilic thiolate 
species. Figure 4.11 shows 
the XIC of the products with m/z 850.46
+2
, i.e. the native H293W peptide and product 1. Figure 
4.11A displays the H293W peptide after irradiation, and Figure 4.11B displays the H293W 
peptide after irradiation with GSSG. Both XIC chromatograms look nearly identical, and there 
was no trace of m/z 437.4, the m/z value corresponding to the 3-MEI trapped with reduced L-
glutathione, as was observed in experiments in Chapter 3, Section 3.3. Since this trapping 
experiment was unsuccessful, we assumed that the intramolecular isobaric product formation 
was much quicker than an intermolecular reaction. Another possible reason this trapping 
experiment was not successful is due to the presence of O2 during the photolytic reaction. The 
reaction should have been done in Ar so O2 would not react with the photolytically generated 
thiyl radicals and Trp radical cations, inhibiting the formation and reaction of 3-MEI with 
glutathione. 
Figure 4.11. Extracted ion chromatograms (XIC) from H293W peptides (A) 
after irradiation at  = 254 nm in water at pH 7.0 and (B) after irradiation with 





v. Blocking the H293W Lys Amine Reactivity by Methylation. To inhibit the formation of 
product 1, the Lys amines were di-methylated to block their nucleophilic propensity. In separate 
experiments, following the photolysis of H293W and subsequent formation of product 1, the 
samples were also methylated. In this case, methylation of the N-terminal amine in product 1 
was unexpected, as the 3-MEI group on the N-terminal Lys should inhibit the Lys group from 
reacting with the methylation reagents. 
Both Lys residues in the H293W peptide were di-methylated prior to irradiation using a 
reductive alkylation method with formaldehyde and sodium borohydride, thus increasing the 
molecular weight of the peptide by 56 Da. This H293W peptide derivative will be labeled as 
H293WK in the following sections. Figure 4.12 shows the MS/MS spectrum of the control 




. The b1 ion now shows an increase in 28 Da 





compared to the original b1 ion in the H293W peptide (Figure 4.6), confirming methylation on 
the N-terminal Lys residue. Likewise, the m/z value of the y1 ion also corresponds to an increase 
of 28 Da compared to the b1 ion of the unmodified C-terminal Lys in H293W. The rest of the b 
and y ions in H293WK are consistent with unmodified residues on the interior of the peptide.  
The H293WK peptide and the H293W peptide were dissolved in water to a concentration 
of 100 µM at pH 4.0, saturated with O2, and irradiated at λ = 254 for 20 minutes. Then, after 
irradiation, an aliquot of the H293W sample was methylated under the same methylation 
conditions as mentioned above. The resultant products were then analyzed by LC-MS/MS using 
the Q-tof Premier.   
Figure 4.13 shows the XIC of m/z 850.5
+2
 for the H293W peptide after irradiation 
(Figure 4.13A), the XIC of m/z 878.5
+2
 for the H293WK peptide after irradiation (Figure 4.13B), 
Figure 4.13. Extracted ion chromatograms (XIC) from (A) H293W after irradiation; (B) H293WK after irradiation 





and the XIC of m/z 878.5
+2
 for the H293W peptide after irradiation, then methylation (Figure 
4.13C). In all the spectra, the native, unmodified peak elutes at ca. 24 minutes, and an isobaric 
product elutes ca. 2 minutes earlier, at 22 minutes. We expected product 1 to appear during the 
irradiation of the H293W peptide, but it was unexpected to see an isobaric product, from here on 
notated as product 2a/2b, in Figure 4.13B, when the Lys residues were methylated before 
irradiation. Table 4.3 shows the proposed structures of products 2a and 2b. Furthermore, the 
peak area of product 2a/2b in Figure 4.13B was three times more (ca. 30%) than the peak area of 
product 1 (ca. 10%) in Figure 4.13A, although the samples were irradiated for the same amount 
of time at similar concentrations. Interestingly, when the H293W peptide was first irradiated, 
forming product 1, followed by methylation (Figure 4.13C), product 2a/2b (m/z 878.47
+2
) was 
detected, not product 1 (m/z 850.45
+2
). We expected the 3-MEI attached to the N-terminal Lys in 
product 1 to inhibit the reactivity of the methylation reagents towards the N-terminal Lys, 
however, this was not observed. When the MS/MS spectra of product 2a/2b from both Figure 




4.13B and Figure 4.13C were compared to each other and to the control H293WK peptide (Figure 
4.12), the MS/MS spectra of product 2a/2b was similar between the two experiments, and 
dissimilar to the control H293WK peptide. Figure 4.14 shows the MS/MS spectrum of the 
product 2a/2b generated after the irradiation of the H293WK peptide. The y fragmentation 
(through y10) is identical to that of the native, unmodified peptide (Figure 4.18), and the b1 and 
b2 ions are consistent with no 3-MEI addition to the Lys, but there is one ion missing from the b 
ion fragmentation: the b3 ion. The lack of the b3 ion suggests that either the Tyr hydroxyl group 
abstracted the Trp side chain (product 2a) or a crosslink between the Trp and Tyr residues has 
formed (product 2b), however, we cannot distinguish between the two structures in this 
experiment, so both structures are presented. The presence of product 2a/2b after the Lys amines 
were blocked suggests that the Trp side chain is still cleaved, but since it cannot be trapped by 
Figure 4.14. MS/MS spectrum of product 2a/2b. The W* and Y* represent modified Trp and Tyr residues consistent 




the Lys side chain, another pathway is favored. This second pathway forming product 2a/2b was 
always a possibility, as evidenced by the fact that we observed product 2a/2b when the H293W 
peptide was first irradiated, then reductively alkylated (Figure 4.13C), however the Lys amine is 
a better nucleophile than the Tyr hydroxyl group, so product 1 is favored when the Lys is freely 
available. 
vi. Chymotryptic Digestion of H293WK. To confirm the involvement of the Tyr residue in 
product 2a/2b, the irradiated H293WK peptide was digested with the Sigma-Aldrich trypsin that 
contained chymotryptic activity. Therefore, if the photolytically cleaved Trp side chain is 
connected to the Tyr hydroxyl group or if there is a crosslink between the Trp and Tyr, the 
chymotrypsin will most likely not recognize the modified Tyr as a substrate and no C-terminal 
Figure 4.15. LC-MS of the tryptic/chymotryptic digest for the (A) H293WK control (non-irradiated); (B) irradiated 
H293WK; and (C) irradiated H293W, followed by methylation. 
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Tyr cleavage will occur. Conversely, if the Tyr is not involved, (like the control, non-irradiated 
peptide) the C-terminal cleavage of the Tyr group in product 2a/2b will occur during the 
digestion. 
The control H293WK peptide, irradiated H293WK sample, and the irradiated H293W 
sample followed by methylation were all digested with chymotrypsin. First, the pH of the 
samples was adjusted to pH 7.8 with ammonium bicarbonate buffer, then trypsin was added to 
the samples in a 1:20 enzyme to protein ratio and incubated at 37 °C for four hours.  
Figure 4.15 shows the LC-MS of the chymotryptic digest for the control H293WK peptide 
(Figure 4.15A), the irradiated H293WK sample (Figure 4.15B), and the irradiated H293W 
peptide followed by Lys methylation (Figure 4.15C). No tryptic peptides were observed, just 
chymotryptic peptides, since the Lys residues were methylated, and the enzyme did not 
recognize the modified Lys residues as substrates. This lack of tryptic digestion is further 
evidence for the product 1 structure to contain the Lys-3-methyleneindolenine crosslink 
proposed in Table 4.2. The largest peak in the LC-MS for the control H293WK peptide (Figure 
4.15A) was the Ac-K(+28)NWY peptide peak, m/z 680.36, where the ‘+28’ indicates the double 
methylation of the Lys residues. The other chymotryptic peaks present in Figure 4.15A were 
VDGVEVHNAK(+28) (m/z 1094.67), VDGVEVH (m/z 754.40), Ac-K(+28)NW (m/z 517.30), 
and YVDGVEVHNAK(+28)-Am (m/z 1257.73). There was also a trace of the undigested 
control H293WK peptide at 24.2 minutes, where it eluted in the non-digested control (Figure 
4.13B and C). Following the digest of the irradiated H293WK sample (Figure 4.15B), and the 
irradiated H293W peptide followed by irradiation (Figure 4.15C), the largest peaks in the 
chromatogram were again at 21.5 minutes, but the MS/MS spectra did not match that of Ac-
K(+28)NWY (m/z 680.36). Instead, the main fragment ions in the chromatogram for Figure 
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4.21B and C were m/z 1755.91 and m/z 1756.04, respectively. Furthermore, both MS/MS 
fragmentation patterns matched that of the control H293WK peptide, although the control 
H293WK peptide elutes at 24.5 minutes and product 2a/2b elutes at 22 minutes. The absence of 
m/z 680.36 in the irradiated, methylated samples (Figure 4.15B and C) indicates that 
chymotrypsin did not recognize the Tyr as a substrate like it did in the control (Figure 4.15A), 
thereby not cleaving the peptide C-terminal to the Tyr residue: Ac-K(+28)NWY. However, the 
other chymotryptic peaks (m/z 1094.6, m/z 754.4, m/z 517.3, and m/z 1257.7) observed in the 
control were also observed after irradiation. In addition, peaks corresponding to the oxidation of 
the Trp residue were also observed in Figure 4.15B (m/z 1772.02 and m/z 1431.72), along with 
chymotryptic cleavage C-terminal to the His residue (m/z 1415.76).  





vii. Blocking the H293W Lys Amine and Tyr Hydroxyl group Reactivity by Acetylation. 
To further confirm the Tyr involvement in product 2a/2b after irradiation of H293WK, we 
decided to acetylate both the Tyr and Lys reactive sites to inhibit formation of both product 1 and 
2a/2b. N-succinimidyl acetate was added to the H293W peptide in pH 9.0 phosphate buffer, and 
reacted at room temperature for 15 minutes, generating an acetylated peptide with an increase in 
molecular weight of 126 Da relative to the H293W peptide (a 42 Da increase on each Lys and 




. This peptide will be notated as H293WKY. This 
peptide was purified by HPLC prior to use, and analyzed by LC-MS/MS on the Q-tof Premier. 
The MS/MS of peptide H293WKY is shown in Figure 4.16. The b1 ion has increased 42 Da 
compared to the original b1 ion in the H293W peptide (Figure 4.6), confirming acetylation on 
the N-terminal Lys residue. Likewise, the b3, b4, y10, and y11 ions confirm the acetylation of 
the Tyr residue, and the b13 ion confirms the acetylation of the C-terminal Lys.  





The H293WKY peptide was dissolved in water to a concentration of 100 µM at pH 4.0, 
saturated with O2, and irradiated at λ = 254 for 20 minutes. The resultant products were then 
analyzed by LC-MS/MS using the Q-tof Premier. Figure 4.17 shows the XIC of m/z 1825.87 for 
the control (Figure 4.17A) and irradiated sample (4.17B). Both chromatograms show the peak 
for the native peptide at 24.8 minutes. In the irradiated sample, the intensity of the native peak is 
reduced, but importantly, no isobaric product is observed. Clearly, the Tyr residue was involved 
in the formation of product 2a/2b. 
4.4 Discussion  
In recent photo-oxidation studies, detection of double and triple His oxidation in the Fc 
region of IgG1 molecules was observed, motivating us to study the mechanism of such His 
oxidation using model peptides.
16
 A common thread between the His oxidation products was the 
close proximity in primary sequence to a Trp residue. Since Trp is the most sensitive amino acid 
towards photodegradation,
26
 we hypothesized that nearby Trp residues mediated the His 
oxidation via catalytic oxidation of water and generation of hydrogen peroxide.
27,28 
Model 
peptides for His[293, HC] and His[318, HC] were synthesized to test this hypothesis. Synthesis 
of mutant model peptides with Ala residues instead of Trp residues were also studied. However, 
when the model peptides were irradiated, little His oxidation was detected on any of the model 
peptides. Only H318A, an Ala-containing model peptide was triply oxidized at the His residue. 
Interestingly, the H318A peptide contained no aromatic residues, whereas the H293A, H293W, 
and H318W peptides contained Tyr, Tyr and Trp, and Trp, respectively. In the model peptides 
H318W and H293W, the major oxidation products were Trp oxidation products. Since the only 
model peptide that was triply oxidized was an Ala-containing one, we cannot say that Trp was 
involved in the formation of the oxidized His in the model peptides, and most likely not involved 
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in mAb A either. Of course, the conformation of an antibody is much different than that of a 
model peptide. Most of the residues in small peptides are solvent exposed, whereas in a protein, 
residues can be buried and inert to oxidizing agents and light. In a protein, there are also many 
other residues that can quench the Trp excited state, such as Tyr, Phe, and the disulfide 
bond.
4,29,30
 Since the Trp residues are exposed in the model peptides, Trp absorbs almost all of 
the light, generating most of the photoproducts so mechanistically, these model peptides were 
not appropriate to determine the mechanism of His oxidation in proteins. However, the MS/MS 
data of the oxidized H318A model peptide was helpful in determining the possible structure for 
the triply oxidized His products. The major ion in each spectrum was neither a b or y ion, but a 
doubly charged molecular ion with a neutral loss of water or ammonia. Another interesting 
observation in these spectra was the abundance of neutral losses on the y and b ions when the 





oxidized His residue was contained in the sequence. These fragmentation patterns are indicative 
of free amines and carboxylic acids, generating more charged residues on the peptide. These two 
peptides do contain charged amino acids at pH 4.0 (K, D, E, H), but the non-oxidized peptides do 
not show many neutral fragments. Therefore, the oxidation of His must open up the imidazole 
ring, exposing free amines and carboxylic acids that are easily fragmented through gas-phase 
chemistry. In Scheme 4.2, a proposed photo-oxidative mechanism and structure of triply 
oxidized His is presented. Singlet oxygen initiates the oxidation of His, generating isomeric 
endo-peroxides on the imidazole ring (reactions 1 and 5).
22
 These intermediates lead to the 
formation of a pair of hydroxylated imidazolones (reactions 2 and 6). In one pathway, water can 
then hydrolyze the amide bond on the hydroxyl imidazolone ring, cleaving it to yield a product 
with carboxylic and amide functions and an increase in molecular weight of 48 Da (reaction 7). 
This structure is a good candidate for the triply oxidized His product observed in our studies 
because both water or ammonia can easily be cleaved from the structure during gas phase MS 
fragmentation. Another pathway involves the oxidation of the hydroxyl imidazolone ring, 
generating a triply oxidized His with an intact ring (reaction 3). The hydroxyl group on the His 
γ
C will oxidize, opening the ring, yielding a ketone and free aldehyde on the triply oxidized His 
residue (reaction 4). The triply oxidized His resides generated from reactions 3 and 4 would not 
likely show neutral losses of ammonia or water, but likely losses of 28 Da from CO.  
The highest yielding photoproduct observed in the H293W peptide, product 1, was an 
isobaric product with the same m/z value as the native peptide, but eluting ca. 2 minutes ahead of 
the native, non-modified peptide in a separate peak (Figure 4.4A and 4.4B). The MS/MS of 
product 1 (Figure 4.7) was nearly identical to the MS/MS of the native peptide (Figure 4.6), 
except for the absence of the b1, b2, and b3 ions. Further structural characterization of product 1 
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was consistent with Trp side chain cleavage and abstraction of the resultant 3-
methyleneindolenine (3-MEI) by the N-terminal Lys. Similar Trp side chain cleavages have been 
observed in IgG1
18
 and the octreotide peptide, in which the 3-MEI was abstracted by a nearby 
Lys residue as well.
19
 Alternative structures we explored for product 1 included the 
transformation of L- to D-Trp and the oxidation of Trp to Ky in addition to two crosslinks 
between the Ac-KNW region of the peptide. These structures were rejected after we observed the 
inability of trypsin to cleave the N-terminal Lys in product 1, confirming the modification of 
both the Lys and Trp groups through the transformation of Trp to Gly and the abstraction of 3-
MEI on the Lys amine (Figure 4.8). The proposed mechanism of product 1 generated through the 
photo-oxidation of the H293W peptide is presented in Scheme 4.3. Initially, upon photo-






oxidation, the Trp is photoionized to a Trp radical cation (TrpNH
+•
) while releasing an electron 
from its shell, which is quickly solvated by water (reaction 8). Ground state triplet oxygen is also 
reduced to a superoxide radical. The Trp radical then migrates to the 
γ
C of the Trp residue 




C bond of the Trp residue, yielding a 
Glycyl radical and the free Trp side chain, i.e. 3-MEI (reaction 10). Due to its electrophilic 
nature, 3-MEI, is quickly abstracted by the nearby N-terminal Lys amine (reaction 11). The 
amine group is neutralized when the superoxide anion abstracts a proton from the Lys amine 
group (reaction 12), then the Glycyl radical is neutralized with the hydroperoxyl group (reaction 
13), yielding the final product.  
To inhibit the reaction of the N-terminal Lys with 3-MEI during irradiation, the reactivity 
of Lys was blocked by the addition of methyl groups on the Lys amines the H293WK peptide. 
The Lys groups were also methylated after irradiation of the H293W peptide to distinguish the 
m/z of product 1 with the methylated H293WK peptide since the N-terminal Lys in product 1 
would be unable to react with the methylation reagents. Interestingly, in both sets of methylation 
experiments, isobaric products to the H293WK peptide were observed, product 2a/2b (Figure 
4.13). The MS/MS spectra of product 2a/2b formed after irradiation of H293WK and irradiation 
of H293W followed by methylation were identical, hinting toward the Trp to Gly conversion 
product and Tyr abstraction of the resultant 3-MEI group (product 2a) or a crosslink between the 
Trp and Tyr residues (product 2b). However, from the MS/MS data for product 2a/2b, we could 
not confirm the exact structure of the isobaric product. Until further experimentation is done, 
both possible structures for the Tyr involvement in product 2a/2b have been presented, although 
there could be other possibilities. It was interesting that the product 2a/2b, and not product 1, 
was observed after irradiation of H293W, followed by methylation, because the N-terminal Lys-
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3-MEI crosslink in product 1 should have rendered the Lys unavailable for methylation. One 
explanation for the absence of product 1 following the methylation of H293W after irradiation is 
that product 1 degraded during the reductive environment of the methylation process, whereas 
product 2a/2b did not. Chymotryptic digest of product 2a/2b confirmed the Tyr involvement in 
the product because the enzyme did not recognize the Tyr, thereby not cleaving C-terminal to the 
Tyr residue like it had in the control H293WK peptide (Figure 4.15).  
In Scheme 4.4, the proposed reaction mechanisms of product 2a and 2b are shown. In 
Pathway 1, the mechanism for the Tyr-Trp side chain product is presented, product 2a, and in 
Pathway 2, the mechanism for a Tyr side chain-backbone cyclization product, product 2b is 






presented. Both pathways are initiated in the same way as product 1 formation as shown in 
Scheme 4.3: Trp photoionization (reaction 14) and radical migration to the 
γ
C of the Trp residue 




C bond of the Trp residue, 
yielding a Glycyl radical and the free Trp side chain, 3-MEI (reaction 16). However, instead of 
the N-terminal Lys abstracting 3-MEI as was the case in product 1, the Tyr hydroxyl group 
reacts with it (reaction 17). The newly formed ether bond with the Tyr hydroxyl group is 
neutralized when the superoxide anion abstracted the extra proton (reaction 18), then the Glycyl 
radical is neutralized with the hydroperoxyl group (reaction 19), yielding product 2a, a Tyr-3-
MEI crosslink. In Pathway 2, the Trp side chain is not cleaved, but following the radical 
migration of the radical to the 
γ
C of the Trp residue (reaction 15), the Tyr amide nitrogen 
abstracts the C-centered radical from the Trp (reaction 20). Then, a crosslink between 
hydroxyphenyl side chain and the nitrogen forms, creating an indole heterocycle and C-centered 
radical on the hydroxyphenyl ring (reaction 21) that is stabilized through resonance with the 
hydroxyl group (not shown). The superoxide anion also abstracts the proton from the Trp cation 
to form the hydroperoxyl radical and neutralize the Trp residue. The C-centered radical abstracts 
an H-atom from the hydroperoxyl radical (reaction 22), creating product 2b, which can isomerize 
from the enol to keto form (reaction 23).  
Interestingly, the formation of products 1, 2a and 2b all rely on reactive oxygen species 
(superoxide and hydroperoxyl radicals) as reducing agents, but Trp to Gly hydroperoxide was 
not detected. These Trp side chain cleavage products were only observed in one Trp-containing 
peptide, H293W, and not H318W, highlighting the importance of protein conformation on 
protein stability and photoproduct formation. The H293W peptide contained nucleophilic Lys 
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and Tyr residues in close proximity to the Trp residue, whereas the H318W peptide did not 
contain any nucleophilic amino acids in close proximity. 
4.5 Conclusion 
A triply oxidized His residue was detected after photo-oxidation studies in an Ala-
containing peptide modeled after a tryptic peptide found in the Fc region of IgG1 molecules. 
Although the oxidation of His is a small degradation product, the oxidation could affect the 
overall stability and efficacy of the IgG1, and if the His ring is opened upon oxidation, 
nucleophilic residues are exposed for protein aggregation. Interestingly, in a Trp-containing 
peptide, the Trp side chain was photolytically cleaved and trapped by a neighboring Lys residue, 
and when the Lys residue was methylated to block reactivity, the neighboring Tyr residue was 
involved in the reaction. If the Trp side chains in proteins are cleaved, there are many possible 
nucleophilic amino acids nearby that could trap the side chain. This could lead to protein 
instability or lowered efficacy if the Trp or the Trp side chain trapping residue is involved in 
antigen binding or receptor recognition. This work also highlights the significant conformational 
differences between model peptides and proteins, and the importance of light stress studies in 
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Figure C.1. MS/MS of the control H318W model peptide. 
 
 
Figure C.2. MS/MS of the Trp to Asp conversion product after irradiation of the H318W 



















Figure C.3. MS/MS of the control H293W model peptide after Glu-C digestion.  
 
Figure C.4. MS/MS of the isobaric product, product 1, after Glu-C digestion.  This product 
was formed during the irradiation of the H293W model peptide at  = 254 nm in water at pH 
4.0. 






Figure C.5. LC-MS of the H293W tryptic digest (using the Sigma -Aldrich trypsin) in the (A) control (non-
irradiated) and (B) irradiated samples after irradiation of 100 µM H293W at  = 254 nm in water at pH 4.0. 
Surprisingly, along with tryptic peptides, many chymotryptic peptides were also observed during the tryptic 
digest using the Sigma-Aldrich trypsin. The two tryptic peptides observed in the control H293W peptide (Figure 
C.5A) were the single (24.5 minutes) and double (21.5 minutes) C-terminal cleavage of the Lys residue: Ac-
KNWYVDGVEVHNAK and NWYVDGVEVHNAK, respectively. The rest of the peptides observed in the 
chromatogram were chymotryptic peptides, created by the C-terminal cleavage of the Trp, Tyr, and His residues. 
In fact, the largest peak in the chromatogram was the chymotryptic peptide Ac-KNWY, eluting at 21.5 minutes. 
The tryptic digest of the irradiated H293W sample contained new peaks, in addition to those observed in the 
control (Figure C.5B). For instance, the tryptic fragment of the oxidized Trp residue was observed at 22.5 
minutes, but was not present in the control. Two peaks with the same m/z value appeared in the irradiated 
sample: m/z 1700.88 at 21.5 minutes and 24.5 minutes and m/z 1387.78 at 23.5 minutes and 26.5 minutes. The 
peaks at 24.5 and 26.5 minutes were observed in the control, however, the other two peaks were not, and 
therefore, were related to the digest of the isobaric product, product 1. Interestingly, the tryptic digest peak 
observed at 24.5 minutes in the control that did not contain the N-terminal Lys (NWYVDGVEVHNAK) was 
observed in the irradiated sample only once, not twice. The absence of the second NWYVDGVEVHNAK peak 
belonging to the isobaric peptide 1 provides evidence that in the isobaric product, the Lys amine group is 
attached to the Trp side chain, and trypsin was unable to recognize this Lys as a substrate. Unfortunately, the 
NGYVDGVEVHNAK peptide was not observed in this LC-MS. Another interesting product in Figure C.5B 
eluted at 21.5 minutes, and just like the peak in Figure C.5A, contained the m/z value 652.32 matching the Ac-
KNWY peptide. However, the MS/MS fragmentation of this product did not match that of Ac-KNWY, but 
contained the y fragment ions from the peptide YVDGVEVHNAK, but no b ions. We suspect this peak may 
contain multiple products, but since the MS
E
 method was used, it was difficult to distinguish the fragmentation 




































5.1 Summary and conclusions 
 Protein therapeutics are often more effective against a variety of diseases than small 
molecule drugs because of their superior efficiency and affinity toward their targets.
1,2
 However, 
proteins such as monoclonal antibodies are still sensitive to a number of chemical and physical 
instabilities such as oxidation and photochemical degradation that hinders their ability to be used 
as commercial drugs for safety and efficacy concerns.
3
 These degradation pathways could 
enhance immunogenicity or cause inactivation.
4,5
 Therefore, to increase the stability of these 
antibodies, an understanding of their mechanisms of degradation is necessary. In proteins, two of 
the most light-sensitive amino acids are Trp and the disulfide bond, and proteins, such as 
monoclonal antibodies, contain multiple disulfides and Trp residues important in maintaining 
their structure and function.
6
 Therefore, the aim of this dissertation project was to further 
investigate protein stability in proteins and model peptides containing Trp and/or disulfide bonds 
to help elucidate novel mechanisms of protein degradation to lead to a greater understanding of 
protein stability.  
 
Chapter 2 details the reactions of the disulfide-containing peptides (LGVCVGL)2, in which the 
Val residues displayed natural C-isotope distribution or were uniformly 
13
C labeled at either the 
i+1 or i-1 position. Our results demonstrated that the photolytically or radically initiated thiyl 
radicals reacted with the Val residues as had been observed in previous model peptides such as 
(GGCGGL)2 and (LGACAGL)2 to form dehydroamino acids. Interestingly, thiyl radicals also 
entered a new pathway not observed before, forming an isothiazole-3(2H)-one product in a 90% 
yield after 1 minute of irradiation. The formation of this product is likely the result of steric 
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constraints from the bulky Val residues, disfavoring intermolecular reactions for intramolecular 
reactions with thiyl radicals.  
 
Chapter 3 elucidates a mechanism for the photolytic Trp side chain cleavage and transformation 
of Trp into Gly and/or Gly hydroperoxide. These reaction products were observed in three 
locations on the IgG1 molecule studied and three Trp and disulfide-containing model peptide 
systems. In the IgG1, each affected Trp residue was in close proximity to a disulfide bond, 
highlighting the importance of Trp and disulfide interactions to form this modification. The 




C cleavage of the Trp side chain, resulting in a glycyl radical reduced to Gly by H-atom 
transfer from thiol residues or Gly hydroperoxide by oxygen.  
 
Chapter 4 identifies a novel triply oxidized His residue in an IgG1 molecule and a model 
peptide, and characterizes the photo-oxidative Trp side chain cleavage in the absence of a 
disulfide in a Trp-containing model peptide. Chapter 3 hypothesizes that H-atom transfer from 
Cys thiol residues is important in reducing the Trp to Gly, however, in a Trp-containing model 
peptide with no Cys residues, the Trp side chain was cleaved, and a nearby Lys residue 
abstracted it. Interestingly, another reaction pathway was also observed when the Lys residues 
were methylated, where the Tyr residue abstracted the Trp side chain.  
 
The Cys crosslinks and Trp cleavage products highlight the damage light exposure can 
have by not only inducing significant amino acid modifications, but also modifications that could 
lead to protein aggregation or amino acid hydroperoxides that have the potential to induce 
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additional protein oxidation. The products identified and reaction schemes proposed have given 
us greater understanding of protein stability towards reactive thiyl and Trp radical cations 
generated photolytically.  
5.2 Future directions 
 For the photolytically generated reaction products we observed in IgG1 and the model 
peptides, it would be interesting to examine their biological activity and effect on protein 
efficacy and/or safety, since that is what is ultimately important in the pharmaceutical industry. If 
we did see lowered biological activity or increased immunogenicity in IgG1, it would be difficult 
to deduce which protein modifications were the root cause. However, with peptides, we can 
easily collect and purify the modified peptides for biological testing.  
 Interestingly, some of our photoproducts contained dehydroamino acids and heterocycles, 
such as the isothiazol-3(2H)-one. Many antimicrobial peptides and peptide derivatives have 
unique modifications that increase their potency and activity, such as dehydroamino acids, D-
amino acids, and heterocyclic moieties, and it is reported that peptide backbones can cyclize to 
heterocycles via synthetic pathways.
7
  For example, penicillin and cephalosporin, common small 
molecule drugs with peptide characteristics, are both comprised of sulfur-containing 
heterocycles. Our work to discover novel protein modifications via photolysis could fill the niche 
as a simple and efficient method to modify amino acids to be used as starting materials for 
antimicrobial peptides. Importantly, the development of new antimicrobial peptides is vital 
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